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Obesity is a metabolic disease accompanied by a disruption in the immune system 
leading to systemic inflammation and susceptibility to infections. Leptin, the peptide secreted by 
adipocytes in proportion to fat mass, is primarily a metabolic hormone translating the body’s 
energy status to the brain.  Leptin is also a pro-inflammatory cytokine and leptin deficiency is 
associated with higher infection susceptibility and a protection against autoimmune diseases. 
Leptin’s dual metabolic-immune function places this hormone as the link between metabolic 
disturbances of obesity and the immune system. In the following research projects, the 
contribution of leptin to both inflammation and infection susceptibility was investigated in a 
murine model of diet-induced obesity.  
Chimeric mice with leptin receptor-deficient bone marrow were resistant to HFD-induced 
weight and fat mass gain. These mice exhibited less inflammation in the adipose tissue 
demonstrated by a blunted increase in tnfa and il6 gene transcript levels, a higher prevalence of 
anti-inflammatory macrophages and a lower number of crown-like structures. Systemically, 
these mice showed a tendency towards higher insulin sensitivity. These outcomes were 
compared to those from mice with wild-type bone marrow. Obese and lean mice exhibited 
similar kinetics of bacterial clearance and systemic leptin changes following infection with 
Ehrlichia chaffeensis in vivo. Nevertheless, isolated “obese” peritoneal macrophages were 
significantly less phagocytic than macrophages from lean mice and supplementation with leptin 
significantly increased the obese macrophages' phagocytic activity with no effect on lean 
macrophages. A cell line, DB-1, derived from leptin receptor-deficient bone marrow was 
immortalized and characterized. This cell line has phenotypic and functional properties 
characteristic of macrophages, lacks the long isoform of the leptin receptor, and is unresponsive 
to leptin.  
The data from the above mentioned studies suggest that leptin contributes to the 
inflammation of obesity. They also suggest that leptin affects macrophage function in obesity in 
vitro though more studies are required to assess leptin’s contribution to infection outcomes in 
vivo. Finally, DB-1 cells provide a dependable tool to study the role of leptin in obesity-
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Obesity is a metabolic disease accompanied by a disruption in the immune system 
leading to systemic inflammation and susceptibility to infections. Leptin, the peptide secreted by 
adipocytes in proportion to fat mass, is primarily a metabolic hormone translating the body’s 
energy status to the brain.  Leptin is also a pro-inflammatory cytokine and leptin deficiency is 
associated with higher infection susceptibility and a protection against autoimmune diseases. 
Leptin’s dual metabolic-immune function places this hormone as the link between metabolic 
disturbances of obesity and the immune system. In the following research projects, the 
contribution of leptin to both inflammation and infection susceptibility was investigated in a 
murine model of diet-induced obesity.  
Chimeric mice with leptin receptor-deficient bone marrow were resistant to HFD-induced 
weight and fat mass gain. These mice exhibited less inflammation in the adipose tissue 
demonstrated by a blunted increase in tnfa and il6 gene transcript levels, a higher prevalence of 
anti-inflammatory macrophages and a lower number of crown-like structures. Systemically, 
these mice showed a tendency towards higher insulin sensitivity. These outcomes were 
compared to those from mice with wild-type bone marrow. Obese and lean mice exhibited 
similar kinetics of bacterial clearance and systemic leptin changes following infection with 
Ehrlichia chaffeensis in vivo. Nevertheless, isolated “obese” peritoneal macrophages were 
significantly less phagocytic than macrophages from lean mice and supplementation with leptin 
significantly increased the obese macrophages' phagocytic activity with no effect on lean 
macrophages. A cell line, DB-1, derived from leptin receptor-deficient bone marrow was 
immortalized and characterized. This cell line has phenotypic and functional properties 
characteristic of macrophages, lacks the long isoform of the leptin receptor, and is unresponsive 
to leptin.  
The data from the above mentioned studies suggest that leptin contributes to the 
inflammation of obesity. They also suggest that leptin affects macrophage function in obesity in 
vitro though more studies are required to assess leptin’s contribution to infection outcomes in 
vivo. Finally, DB-1 cells provide a dependable tool to study further the role of leptin in obesity-
associated inflammation and immune system dysregulation. 
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Chapter 1 - Obesity: a condition of metabolic inflammation and 
compromised immune response 
 Prevalence and Implications of Obesity 
Obesity, or the state of excess fat mass, is the 21st century’s major epidemic disease 
(Caterson, Hubbard et al. 2004). Obesity rates have increased steadily for the past 30 years in 
both developed and underdeveloped countries. Currently, more than 1 billion adults are 
overweight (body mass index (BMI)>25) globally, and of those 300 million are obese (BMI>30). 
By 2015, 700 million people are estimated to be obese worldwide 
(http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/). Based on the latest 
National Health and Nutrition Examination Survey (NHANES), approximately 66% of the U.S. 
adult population is classified as overweight and more than 30% is obese (Ogden, Carroll et al. 
2006). More alarming is the increased prevalence of childhood obesity; according to the 
NHANES data for 2007-2008, 32% of children and adolescents aged 2 to 19 years, are at or 
above the 85th percentile of BMI for age  (Ogden, Carroll et al.). As for the economical burden 
associated with obesity, a 2003 study estimated medical expenditure attributed to obesity to 
equal $75 billion, equivalent to 9.1 percent of overall U.S. health expenditures (Finkelstein, 
Fiebelkorn et al. 2004). 
A plethora of morbidities associated with excess weight further highlights the seriousness 
of this situation. Obesity is positively correlated with insulin resistance, diabetes mellitus (DM), 
atherosclerosis, cardiovascular disease (CVD), some forms of cancer and fatty liver disease (Pi-
Sunyer 1993; Shoelson, Herrero et al. 2007) . In addition, abdominal obesity by itself, is a major 
risk factor for metabolic syndrome, a constellation of conditions that significantly increases the 
risk of coronary artery disease and other health problems, including diabetes and stroke (Grundy, 
Brewer et al. 2004).  Although metabolic disorders such as DM, CVD and cancer are the major 
contributors to the increased morbidity and mortality rates in obesity, chronic and acute 
respiratory infections, including bronchitis, pneumonia, tuberculosis, septicemia, and other 
infections, also contribute to substantial adult mortality in obese individuals (Flegal, Graubard et 
2 
 
al. 2007). This highlights the fact that obesity-related morbidities are not limited to metabolic 
disturbances, but encompass immunological responses as well. 
With the rapid growth in the number of overweight individuals, significant research 
currently focuses on illuminating the link between the plethora of morbidities, disease 
susceptibility and obesity.   
 Metabolic and Immune Systems: An Evolutionary Perspective 
Throughout evolution, species survival depended on the ability to withstand starvation 
and the capacity to successfully clear pathogens (Dixit 2008). The scarcity of food and infectious 
epidemics and pandemics through evolution shaped a “thrifty” genetic profile. This genetic 
profile favors caloric storage of excess calories as fat and strong antibacterial immune responses 
(Levin, Lipsitch et al. 1999; Ames 2006).  It is hypothesized that both metabolic and immune 
functions share common or overlapping pathways regulated through common key molecules and 
signaling systems (Hotamisligil 2006). In fact, primitive organisms such as Drosophila integrate 
the pathogen and nutrient sensing pathways such that nutrients can induce immune responses and 
pathogens can evoke and regulate metabolic actions (Levin, Lipsitch et al. 1999; Dionne, Pham 
et al. 2006). Toll-like receptors (TLRs) a family of pattern-recognition receptors, are an example 
of receptors that can be activated by both pathogens and nutrients (Senn 2006; Shi, Kokoeva et 
al. 2006). In fact, lipopolysaccharide (LPS), which is present on the cell wall of gram-negative 
bacteria, binds and activates TLR4. Fatty acids such as palmitate and oleate, which correlate with 
obesity (Gao, Nong et al. 2010), are also ligands for TLR4. Another example for the immune-
metabolic interactions are the 5' adenosine monophosphate-activated protein kinase (AMPK) and 
the mammalian target of rapamycin (mTOR) pathways. Both pathways are involved in energy 
state sensing of the body. In addition, current investigations focus on AMPK and mTOR as 
mediators of the effect of caloric restriction (CR) on increased longevity and improved immune 
functions (Jiang, Zhu et al. 2008). 
A delicate balance exists between metabolic and immune functions. Depending on the 
situation, one of these functions is shut down in order to maximize efficiency of the other. To 
illustrate this concept, activation of inflammatory or stress responses to pathogens inhibit major 
anabolic signaling pathways such as the insulin/insulin-like growth factor (IGF), thus channeling 
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the body’s energy towards fighting the infection rather than towards anabolic mechanisms 
(Garsin, Villanueva et al. 2003). This dual regulation has been efficient and essential to survival 
in the past eras where food supply was erratic and people led a less sedentary lifestyle. However, 
in our current times of food surplus combined with a sedentary lifestyle and hyperhygienic 
environments, our highly efficient metabolic and immune systems are facing alternative 
challenges. In fact obesity is associated with immune disturbances characterized by both chronic 
low grade inflammation (Hotamisligil 2006) and an increased susceptibility to infections 
(Falagas and Kompoti 2006).  This introduction provides an overview of obesity, adipose tissue 
and immune mechanisms relevant to obesity. It will discuss aspects of obesity-associated 
immune disturbances and the role of leptin, a peptide involved both in metabolism and 
immunity, in relation to these disturbances (Figure 1.1). The latter two aspects will be discussed 
in greater details in the following chapters. 
 
 
Figure 1.1 Relationships between obesity, leptin and the immune system.   
Obesity and leptin affect the immune system independently. In addition, obesity and leptin are highly correlated 
suggesting that the coexistence of both can act synergistically on the immune system. 
 
 Leptin:  A Pleiotropic Hormone 
Leptin, the product of the ob gene in rodents and LEP gene in humans, is a 16 kDa 
peptide hormone predominantly secreted by white adipocytes (Zhang, Proenca et al. 1994; 
Ahima and Flier 2000). Leptin belongs to the family of long-chain helical cytokines 
characterized by a four α-helix bundle and shares structural similarities with type I cytokines and 
is referred to as an adipokine or adipocytokine (Otero, Lago et al. 2005). Leptin acts through its 
receptor (LepR) encoded by the db gene in rodents (Chen, Charlat et al. 1996). The leptin 
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receptor is a member of the class I cytokine receptor family (Friedman and Halaas 1998). LepR 
exists in six alternatively spliced isoforms that share the same extracellular domain but differ in 
the length of the intracellular domain (Lee, Proenca et al. 1996). The long isoform (LepRb) has a 
total length of 1162 amino acids and is responsible for most of leptin’s biological activities 
(Tartaglia, Dembski et al. 1995). When leptin binds to LepRb, it recruits Janus tyrosine kinase 2 
(JAK2) and activates the receptor, which then serves as a docking site for signal transducer and 
activator of transcription (STAT) factors, particularly STAT3 (Baumann, Morella et al. 1996). 
STAT3 then translocates to the nucleus and induces expression of other genes, including 
negative regulators, such as the suppressor of cytokine signaling 3 (Bjorbaek, El-Haschimi et al. 
1999) and the protein tyrosine phosphatase 1B (Cheng, Uetani et al. 2002).  Additional pathways 
are also involved in leptin signaling and include the mitogen-activated protein kinase (MAPK), 
the insulin receptor substrate 1 (IRS-1), and the phosphatidylinositol 3 kinase (PI3-K) (Martin-
Romero and Sanchez-Margalet 2001). 
Leptin is a pleiotropic hormone; its major role involves the regulation of neuroendocrine 
function and energy homeostasis (Chan, Heist et al. 2003). Leptin stimulates the production of 
anorectic neuropeptides and suppresses the action of orexigenic peptides in the arcuate nucleus 
of the hypothalamus (Cheung, Thornton et al. 1997; Schwartz, Seeley et al. 1997; Thornton, 
Cheung et al. 1997), where LepRb is highly expressed (Elmquist, Bjorbaek et al. 1998). Since 
leptin was identified as an anti-obesity hormone (Zhang, Proenca et al. 1994), it was expected 
that human obesity,  similarly to the rodent model, will be characterized by leptin deficiency. 
However, contrary to these early assumptions, obese individuals almost always express high 
leptin levels (Considine, Sinha et al. 1996) and their obesity was due to leptin resistance in the 
hypothalamus rather than leptin deficiency (Banks and Farrell 2003; Munzberg and Myers 
2005). 
In addition to being the body’s major energy sensor, leptin exerts other physiological 
effects that impact reproduction, hematopoiesis, angiogenesis and immunity (Wauters, Considine 
et al. 2000). Most of these effects are through a direct action of leptin on peripheral tissues and 
cells that express the functional long leptin receptor.  Leptin plays an important role in the 
regulation of both innate and adaptive immunity (La Cava and Matarese 2004; Matarese, 
Moschos et al. 2005) with most immune cells expressing LepRb (Matarese, Moschos et al. 
2005). T-cells (Batra, Okur et al. 2009), B-cells (Papathanassoglou, El-Haschimi et al. 2006), 
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neutrophils (Caldefie-Chezet, Poulin et al. 2003), monocytes (Raso, Pacilio et al. 2002), dendritic 
cells (Mattioli, Straface et al. 2005) and NK cells (Tian, Sun et al. 2002) all express LepRb, and 
leptin modulates the function both in vivo and in vitro (Papathanassoglou, El-Haschimi et al. 
2006). In innate immunity, leptin modulates the activity and function of neutrophils by 
increasing chemotaxis and the secretion of oxygen radicals (Mancuso, Gottschalk et al. 2002; 
Caldefie-Chezet, Poulin et al. 2003). Leptin acts on monocytes and macrophages by stimulating 
phagocytic activity, the secretion of pro-inflammatory cytokines and expression of adhesion 
molecules (Lord, Matarese et al. 1998; Fantuzzi and Faggioni 2000). It also increases cytotoxic 
ability and the secretion of perforin and IL-2  by natural killer (NK) cells (Tian, Sun et al. 2002). 
In adaptive immunity, leptin affects the generation, maturation and survival of thymic T cells 
(Howard, Lord et al. 1999) and promotes the switch of naïve T-cells (TH0)  towards T helper 1 
(TH1)-cell immune responses by increasing interferon-γ (IFN-γ) and TNF secretion (Lord, 
Matarese et al. 1998).  
Hence, leptin is actively involved in immune system activation.  Indeed, in situations of 
caloric deprivation such as starvation, leptin levels are drastically decreased leading to an 
attenuation of energy demanding mechanisms such as reproductive and immune systems 
(Faggioni, Moser et al. 2000; Matarese, La Cava et al. 2002). On the other hand, in obesity, 
leptin levels are drastically increased to abnormal levels also negatively impacting these 
pathways.  
 Adipose Tissue: More than an Inert Energy Reservoir 
White adipose tissue (WAT) is the only tissue in the body that can significantly change in 
size throughout lifespan and different levels of obesity (Hausman 2001). WAT is best known as 
the body’s unlimited energy store. Nevertheless, adipose tissue is not just an inert fuel storage 
reservoir. Now recognized as an endocrine organ, adipose tissue secretes a multitude of 
substances involved in both energy homeostasis and inflammatory mechanisms through 
paracrine, autocrine and endocrine pathways (Harle and Straub 2006).  Adipose tissue is a major 
source of adipocytokines and other soluble factors. Among the secreted adipocytokines are 
leptin, adiponectin, resistin and visfatin. Tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), 
monocyte chemoattractant protein-1 (MCP-1), plasminogen activator inhibitor-1 (PAI-1), 
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angiotensinogen, retinol-binding protein-4, serum amyloid A (SAA) are also among the soluble 
factors secreted by the adipose tissue (Shimomura, Funahashi et al. 1996; Fried, Bunkin et al. 
1998; Steppan, Bailey et al. 2001; Fukuhara, Matsuda et al. 2005).  Thus, it is clear that adipose 
mass is a complex organ involved in many physiological processes. 
The role of the adipose tissue in the induction of low-grade inflammation of obesity was 
first demonstrated by Hotamisligil and colleagues in 1993. This study showed that adipose tissue 
is an important source of the pro-inflammatory cytokine, TNF-α and its expression, in fat mass, 
increases with obesity. In the same study, neutralization of TNF-α u sin g a TNF-α soluble 
antibody lead to an improvement in insulin sensitivity of obese animals. Although suggested in 
the early 1900s, this study demonstrated, for the first time, a direct mechanistic link between 
inflammatory mediators and metabolic disease (Hotamisligil, Shargill et al. 1993). The early 
studies used salicylates; the non-steroidal anti-inflammatory drug, for the treatment of diabetes 
and high blood sugar (Williamson 1901; Reid, Macdougall et al. 1957) suggesting since that time 
an interaction between immunity and metabolism.   
WAT is divided into subcutaneous and abdominal or visceral stores that differ both at the 
physiological and pathological levels (Shoelson, Herrero et al. 2007).  The two depots differ in 
their contribution to secreted proteins and cytokines; abdominal WAT produces higher levels of 
adiponectin (Motoshima, Wu et al. 2002), PAI-1, IL-8, IL-6 and IL-1β (Juge-Aubry, Somm et al. 
2003; Bruun, Lihn et al. 2005) whereas subcutaneous WAT secretes higher leptin levels 
(Montague and O'Rahilly 2000; Fain 2006). The two fat depots also differ in cell size, metabolic 
activity, and potential role in insulin resistance (Johnson and Hirsch 1972; Krotkiewski, 
Bjorntorp et al. 1983; Gastaldelli, Miyazaki et al. 2002).  Compared to other fat depots, visceral 
adiposity is highly correlated with increased risk of CVD and diabetes (Wang, Rimm et al. 2005; 
Kuk, Katzmarzyk et al. 2006).  One possible explanation is the “portal hypothesis” which 
suggests that the direct access of visceral fat to the portal circulation allows direct delivery of 
free fatty acids to the liver. This hypothesis may explain the high correlation between this 
particular fat depot and insulin resistance (Kabir, Catalano et al. 2005). In addition to its 
anatomical location,  visceral fat displays a higher lipolytic activity compared to subcutaneous 
fat (Montague and O'Rahilly 2000) releasing more free fatty acid into the circulation and directly 
to the portal system impacting the liver and leading to metabolic abnormalities (Bjorntorp 1990; 
Nielsen, Guo et al. 2004). 
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 Obesity: Chronic Inflammatory State 
Though beneficial in the context of energy balance, the close interplay between metabolic 
and inflammatory pathways, becomes deleterious if this balance is disrupted due to either 
nutrient scarcity or nutrient excess (Wellen and Hotamisligil 2005).  Obesity, or excess fat mass, 
is currently defined as a state of chronic low-grade inflammation (Dandona, Aljada et al. 2004; 
Cancello and Clement 2006).  Human and most rodent obesity models are characterized by an 
increased serum levels of C-reactive protein (CRP), IL-6, IL-18, P-selectin, TNF-α and leptin - 
most of those arising from the expanded adipose tissue mass (Greenberg and Obin 2006; Tilg and 
Moschen 2006).  This sustained systemic elevation of inflammatory markers correlates with the 
development of insulin resistance and atherosclerosis, two hallmarks of the metabolic syndrome 
(Hotamisligil, Peraldi et al. 1996; Cottam, Mattar et al. 2004; Wellen and Hotamisligil 2005; 
Lazar 2006) (Figure 1.2). Indeed, the present consensus supports the fact that most of the 
obesity-associated diseases such as hypertension, diabetes, atherosclerosis, dyslipidemia and 
some forms of cancer are of inflammatory origin (Wellen and Hotamisligil 2005). Pro-
inflammatory cytokines and inflammatory pathways such as TNF-α, IL-6, suppressor of cytokine 
signaling proteins (SOCS), ER stress, NF- B and JNK signaling pathways are all up-regulated in 
obesity and provide different mechanisms for the metabolic-immune dysregulation observed in 
this state  (Rui, Yuan et al. 2002; Croker, Krebs et al. 2003; Ozcan, Cao et al. 2004; Tilg and 
Moschen 2006). Among these mechanisms are, enhanced lipolysis leading to increased systemic 
levels of non-esterified free fatty acids (NEFA), suppressed gene expression of glucose 
transporter GLUT4, disrupted insulin signaling pathway through serine phosphorylation of IRS-
1, and increased production of reactive oxygen species (ROS). All of these alterations lead to 
metabolic disease through insulin resistance and atherosclerosis (Feingold, Doerrler et al. 1992; 




Figure 1.2 Model of inflammation-induced metabolic disease in obesity.  
Obesity leads to adipose tissue expansion mainly through adipocyte hypertrophy. Hypertrophied adipocytes secrete 
cytokines and adipokines into the systemic circulation leading to the low grade inflammatory state reported in 
obesity. This inflammatory state is associated with cytokine-mediated insulin resistance and atherosclerosis.    
 
Since inflammation seems to be at the center of obesity-associated metabolic disorders, 
current research focuses on identifying culprit molecules within the adipose tissue responsible 
for the chronic low grade inflammatory state of obesity. 
 Adipose Tissue Macrophages: Major Player in Obesity Associated Inflammation  
Adipose tissue is a heterogeneous organ consisting of different groups of cells. The most 
abundant cells are the adipocytes (fat cells); other smaller cells constitute the stroma vascular 
fraction (SVF) and include preadipocytes, endothelial cells, fibroblasts, leukocytes and 
macrophages (Tilg and Moschen 2006).  The fact that the adipose tissue consists of a multitude 
of cell types, resulted in  a  debate on the role of each in the secretion of the different adipose 
tissue-derived endocrine and paracrine regulators (Wisse 2004).  Adipocytes secrete most of the 
endocrine hormones such as leptin and adiponectin, whereas other secreted proteins are derived 
primarily from the non-adipocyte fraction of adipose tissue (Fain 2006). In 2003, two large scale 
gene expression studies (Weisberg, McCann et al. 2003; Xu, Barnes et al. 2003) identified 
adipose tissue macrophages (ATMs) as the major source of inflammation in the adipose mass. 
These studies demonstrated that a significant increase in ATMs characterized both genetic and 
diet-induced obesity (DIO) in mice. In fact, ATMs make up to 50% of the total adipose tissue 
cells in extreme cases of obesity (Weisberg, McCann et al. 2003; Xu, Barnes et al. 2003). In 
addition, adipose tissue gene expression of inflammatory cytokines such as TNF-α and 
macrophage inflammatory protein (MIP)-1α is derived almost entirely from macrophages (Xu, 
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Barnes et al. 2003; Fain 2006). Meanwhile, mature adipocytes secrete the majority of leptin, and 
adipocytes, macrophages, and non-macrophage SVF express IL-6 almost equally (Weisberg, 
McCann et al. 2003).  Subsequent studies confirmed these data and further characterized this cell 
population of macrophages strengthening the role of ATMs in obesity-associated inflammatory 
status (Cinti, Mitchell et al. 2005; Lumeng, Bodzin et al. 2007; Lumeng, Deyoung et al. 2007; 
Lumeng, DelProposto et al. 2008). As a result, macrophages are currently considered as central 
players in obesity-induced inflammatory status and its associated metabolic diseases. 
 Resident and Obesity-Recruited Macrophages 
Macrophages are present in the adipose tissue of both lean and obese subjects. In lean 
subjects, they form a constitutive part of the adipose tissue (AT) making up to 10% of the total 
AT cell percentage. Referred to as the resident or type II macrophages, these macrophages are 
F4/80+, CD11c- and MGL1+ and display the anti-inflammatory or M2 gene transcripts such as 
Il10, Mgl1 and Arg1 (Lumeng, Bodzin et al. 2007; Lumeng, DelProposto et al. 2008). These 
macrophages are dispersed in the interstitial space between adipocytes (Cinti, Mitchell et al. 
2005) and are believed to have a role in preserving AT integrity and maintenance. With the onset 
of obesity and the expansion of fat mass, another population of bone-marrow derived 
macrophages is recruited to the adipose tissue. The newly recruited macrophages may comprise 
up to 50% of the total adipose tissue cells in cases of extreme obesity (Weisberg, McCann et al. 
































Figure 1.3 Model of ATM recruitment into the adipose tissue in obesity. 
In the lean state, resident (anti-inflammatory) macrophages are dispersed between adipocytes. With obesity, 
adipocytes increase in size and secrete soluble factors that recruit pro-inflammatory macrophages that form crown-
like structures (CLS) surrounding dying adipocytes 
 
These infiltrated macrophages differ from the resident macrophages in number, 
distribution, phenotype and function. The recruited macrophages display the classical or pro-
inflammatory phenotype (Lumeng, Bodzin et al. 2007) and are referred to as type I or pro-
inflammatory macrophages. With high transcript expression of the M1 or pro-inflammatory gene 
array such as Tnfa, Il6 and Nos2 (Lumeng, Deyoung et al. 2007), the recruited macrophages are 
F4/80+, CD11c+ and MGL1- (Lumeng, Bodzin et al. 2007; Westcott, Delproposto et al. 2009). 
These type I macrophages aggregate around dying adipocytes forming crown-like structures or 
CLS and have a role in the clearance of dying adipocytes (Cinti, Mitchell et al. 2005; Murano, 
Barbatelli et al. 2008) and  adipose tissue angiogenesis (Pang, Gao et al. 2008); two conditions 
resulting from weight gain and the expansion of fat mass (Strissel, Stancheva et al. 2007; 
Murano, Barbatelli et al. 2008).   
Although many of the steps relating obesity to the development of inflammation-induced 
metabolic diseases (more recently described as the “metaflammation” syndrome (Hotamisligil 
2006) have been identified, the exact physiological or secretory factor in the expanded adipose 
tissue  triggering  the onset of pro-inflammatory ATMs recruitment is yet to be identified.  
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 Adipose Tissue Macrophage Recruitment 
Obesity is characterized by an enhanced recruitment of inflammatory macrophages into 
the adipose tissue (Hotamisligil, Shargill et al. 1993; Weisberg, McCann et al. 2003; Xu, Barnes 
et al. 2003).  The factors behind this increased recruitment are yet, not well defined, though 
many soluble physiological factors have been investigated. T-cell infiltration, adipose tissue 
hypoxia, increased angiogenic demand, increased levels of free fatty acids and soluble factors 
such as MCP-1, osteopontin and sLIGHT all contribute to ATMs recruitment, though none of 
these factors can independently, account for this process (Weisberg, Hunter et al. 2006; 
Kintscher, Hartge et al. 2008; Pang, Gao et al. 2008; Rausch, Weisberg et al. 2008; Bertola, 
Deveaux et al. 2009; Kosteli, Sugaru et al. 2010; Kim, Jeong et al. 2011). Chemokine (C-C 
motif) ligand 2 (CCL2) and its receptor chemokine (C-C motif) receptor 2 (CCR2) are to date, 
the best studied chemokine ligand and receptor pair for inducing macrophage accumulation in 
white adipose tissue.  CCL2 and CCR2 recruit monocytes and macrophages to sites of 
inflammation (Maus, Wellmann et al. 2005).  In addition, CCL2 is highly expressed in the 
adipose tissue of obese human subjects and rodents (Sartipy and Loskutoff 2003; Charo and 
Taubman 2004; Bruun, Lihn et al. 2005). Adipose tissue from transgenic diet-induced obese 
(DIO) mice over-expressing CCL2 contains increased number of ATMs. These mice also have a 
higher prevalence of insulin resistance and glucose intolerance compared to DIO WT controls 
(Kamei, Tobe et al. 2006; Kanda, Tateya et al. 2006). These studies suggested CCL2 as the 
major chemoattractant agent for ATMs. However, experiments with CCL2 and CCR2 deficient 
mice produced inconsistent results. Some studies showed that CCR2 KO and CCL2 KO mice on 
a high fat diet (HFD) have a lower inflammatory response and decreased ATMs compared to 
WT mice on the same dietary regimen (Kanda, Tateya et al. 2006; Weisberg, Hunter et al. 2006). 
In addition, the ATMs displayed an anti-inflammatory or alternatively activated profile as 
compared to the DIO WT controls (Lumeng, Deyoung et al. 2007).  On the other hand, 
additional studies showed that CCL2 is not critical for adipose tissue macrophage recruitment 
(Chen, Mumick et al. 2005; Inouye, Shi et al. 2007; Kirk, Sagawa et al. 2008). Inouye et al. and 
Kirk et al. both demonstrated a slight increase in ATMs in DIO CCL2 KO mice as compared to 
WT DIO mice (Inouye, Shi et al. 2007; Kirk, Sagawa et al. 2008). Chen et al. reported no 
differences in the number of ATMs or in plasma insulin or glucose levels in DIO CCR2 KO 
mice compared to DIO WT controls (Chen, Mumick et al. 2005).  In vitro, CCL2 was reportedly 
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a potent chemoattractant for monocytes and macrophages (Gruen, Hao et al. 2007). However, 
these experiments used much higher CCL2 concentrations than the physiological levels seen in 
obesity thus undermining the role of CCL2 in physiological obesity.   
In conclusion, these observations strengthened the belief that other soluble factors, 
probably endogenous to fat mass and positively correlated with fat mass, play a major role in 
ATM recruitment in obesity.  
 Leptin and ATM Recruitment 
Leptin is a good candidate for the soluble factor responsible for the recruitment and pro-
inflammatory differentiation of macrophages into the adipose tissue.  As mentioned previously, 
leptin is secreted by adipocytes and its secretion is proportional to fat mass and adipocyte size.  
In vitro studies showed leptin to be a potent chemoattractant for monocytes and macrophages at 
levels comparable to those measured in obesity (Gruen, Hao et al. 2007). By increasing the 
expression of adhesion molecules in epithelial cells, leptin enhances diapedesis of monocytes 
through an epithelial layer (Curat, Miranville et al. 2004).  In addition, leptin induces pro-
inflammatory or Th1 cytokine secretion by macrophages and monocytes (Lord, Matarese et al. 
1998) while inhibiting a Th2 response. In vivo studies showed that although leptin deficient 
(ob/ob) and leptin receptor-deficient (db/db) mice have increased recruitment of pro-
inflammatory ATMs, the degree of macrophage infiltration was significantly less than expected 
for their bodyweight when compared to WT DIO mice (Weisberg, McCann et al. 2003; Xu, 
Barnes et al. 2003). These data suggested that the absence of leptin or leptin signaling leads to a 
decrease in ATMs recruitment in these genetic models of obesity.  Finally, human obesity is 
characterized by high leptin levels and a prevalence of M1 macrophages in the adipose tissue 
(Clement, Viguerie et al. 2004).  Upon minor weight loss (around 5% of total body weight), 
leptin levels are drastically decreased below that expected for the weight loss (Infanger, 
Baldinger et al. 2003). This is accompanied with a shift in ATMs from an M1 to an M2 
phenotype (Clement, Viguerie et al. 2004). It can be argued that the shift in ATM phenotype 
correlates better with the decrease in leptin rather than with the amount of weight or fat mass 
loss. The evidence presented above and the fact that human obesity is usually a hyperleptinemic 
state, suggest leptin is a strong candidate to enhance recruitment of pro-inflammatory ATMs in 
the obese state.  
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 Obesity, Inflammation and Infection 
Since obesity is a state of chronic low grade inflammation with upregulated levels of pro-
inflammatory cytokines, one might conjecture that this pre-existing inflammatory status would 
impart an advantage to mounting a specific, pro-inflammatory response to clear foreign 
pathogens. However, evidence demonstrates the opposite; obese individuals are more susceptible 
to infections and have a delayed pathogen clearance compared to normal weight controls. 
Indeed, epidemiological and observational studies established a strong link between obesity and 
the development of several types of infections (reviewed in (Falagas and Kompoti 2006). Obese 
people are at higher risk of developing nosocomial, surgical site, odontogenic, respiratory, 
urogenital, skin, bone and liver infections when compared to their leaner counterparts (Falagas 
and Kompoti 2006). 
Both genetically obese (leptin and leptin receptor deficient) and DIO mice exhibit a 
blunted immune response as well as a delayed pathogen clearance when infected with either 
bacterial or viral agents (Mancuso, Gottschalk et al. 2002; Amar, Zhou et al. 2007; Smith, 
Sheridan et al. 2007). In addition, compared to lean controls, infected DIO mice have a higher 
mortality in response to influenza virus infection (Smith, Sheridan et al. 2007).  In vitro studies 
demonstrated impaired phagocytic and bactericidal activity by macrophages isolated from either 
obese humans or mice (Krishnan, Trost et al. 1982; Mancuso, Gottschalk et al. 2002). 
Furthermore, these “obese” macrophages exhibit a blunted cytokine (Amar, Zhou et al. 2007) 
and a defective oxidative response (Zhou, Leeman et al. 2009) upon exposure to an in vitro 
bacterial challenge. 
 Leptin and Infection Susceptibility in Obesity 
Leptin is an adipokine that perfectly illustrates the metabolic-immune dichotomy of 
adipose tissue secreted factors. Genetically obese mice lacking either leptin (ob/ob) or its 
receptor (db/db) are more prone to opportunistic infections and are resistant to autoimmune 
diseases (Sanna, Di Giacomo et al. 2003; Ikejima, Sasaki et al. 2005), highlighting the role of 
functional leptin and leptin signaling in generating normal immune responses.  In fact, restoring 
leptin levels to normal in either ob/ob or starved mice normalized the immune responses in 
bacteria challenged mice (Mancuso, Gottschalk et al. 2002; Sanna, Di Giacomo et al. 2003; 
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Mancuso, Huffnagle et al. 2006).  Similarly, leptin supplementation of macrophages isolated 
from ob/ob mice normalized their phagocytic activity (Mancuso, Gottschalk et al. 2002).  Leptin 
acts on macrophages through activation of JAK/STAT signaling pathway, leading to stimulation 
of phagocytosis, production of oxygen and nitrogen reactive species, and secretion of pro-
inflammatory cytokines (Shirshev and Orlova 2005). 
Leptin signaling and regulation is impaired in obesity, leading to leptin resistance at the 
central nervous system and possibly peripheral levels (Klein, Horowitz et al. 2000; Schwartz, 
Woods et al. 2000).  Influenza infection decreased serum leptin in DIO mice whereas the lean 
group maintained normal leptin concentration. The decrease in leptin in the obese group 
correlated with a higher infection rate (Smith, Sheridan et al. 2007).  In a separate study, leptin 
levels significantly increased after influenza infection in lean mice while this response failed to 
occur in obese mice. Additionally, leptin increase correlated with an improved pathogen 
clearance (Karlsson, Sheridan et al. 2010).  Although these studies reported leptin levels in their 
studies, they did not further investigate if serum leptin change is a causative factor in the 
infection outcome in DIO mice.  
 Dissertation Research Summary 
In the following chapters, the role of leptin is investigated in the context of diet-induced 
obesity on both adipose tissue inflammation and infection susceptibility. A DIO murine model 
lacking leptin signaling in bone marrow cells was used to investigate the role of leptin in the 
recruitment of pro-inflammatory macrophages to the adipose tissue after a 16 weeks period of 
HFD feeding. The outcomes assessed in this study included parameters of adipose tissue 
inflammation and anthropometric and systemic metabolic measures. This study is thoroughly 
described and discussed in Chapter 2. Briefly, the DIO mice with leptin receptor deficient bone 
marrow showed resistance to HFD in terms of body and fat mass weights. These mice exhibited 
higher insulin sensitivity at the systemic level and displayed less inflammation in their adipose 
tissue in terms of inflammatory genes transcript levels, the prevalence of anti-inflammatory 
macrophages and the decreased number of crown-like structures. Leptin’s contribution to 
infection outcomes in obesity was investigated using also a DIO murine model. Obese mice and 
their lean counterparts were injected with Ehrlichia chaffeensis and systemic and bacterial 
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clearance was monitored for 9 days. This study is described in details in Chapter 4. Briefly, no 
significance difference was detected in the kinetics of bacterial clearance between lean and obese 
mice in vivo. Systemic leptin was decreased in both groups after the infection, while 
inflammatory cytokines increased. Nevertheless, macrophage phagocytic activity was decreased 
in vitro in the obese mice and supplementation with leptin restored that function back to normal 
levels. Finally, in Chapter 3, a leptin receptor-deficient cell line, DB-1, is immortalized and 
characterized. This cell line displays phenotypic and functional characteristics of macrophages 




Chapter 2 - Leptin Receptor Contributes to the Metabolic and 
Inflammatory Profile of High Fat Fed Mice 
 Abstract 
Obesity is characterized by an increased recruitment of pro-inflammatory macrophages to 
the adipose tissue leading to systemic inflammation and metabolic disease. We investigated the 
role of leptin receptor in the induction of obesity-associated inflammation. We generated 
radiation chimeric C57BL/6J mice reconstituted with either leptin receptor-deficient (LepR-/-) or 
wild type (WT) bone marrow and kept them on a high fat diet (HFD) for sixteen weeks. 
Anthropometric, serological, and gene expression data, adipose tissue morphology and 
macrophage content were assessed. Mice reconstituted with LepR-/- bone marrow, were resistant 
to HFD-induced weight and fat mass gain.  Epididymal adipocytes in these mice showed a 50% 
reduction in the expression of Tnfa and Il6 and their epididymal fat contained significantly fewer 
crown-like structures compared to mice with WT bone marrow. Most of these macrophages 
expressed Mgl1 and were CCR2 negative, indicative of an anti-inflammatory phenotype. 
Systemically, no difference in serum levels of TNF-α and IL-6 was reported amongst any of the 
groups, but mice reconstituted with LepR-/- bone marrow showed a tendency towards better 
insulin sensitivity. These data suggest that leptin, through its receptor contributes to the 
recruitment of pro-inflammatory macrophages in the adipose tissue of obese mice and the 
expression of the obese phenotype. 
 Introduction 
Obesity is the epidemic disease of this century (Caterson, Hubbard et al. 2004). WHO 
estimate that in 2015, 700 million adults will be obese worldwide 
(http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/). Obesity is positively 
correlated with a plethora of diseases (Pi-Sunyer 1993; Shoelson, Herrero et al. 2007) and a 
higher susceptibility to infections (Falagas and Kompoti 2006). Therefore, investigating the link 
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between the increase in fat mass and the development or exacerbation of disease is of utmost 
importance. 
The close interplay between metabolic and inflammatory pathways is beneficial in the 
context of energy balance but becomes deleterious if this balance is disrupted; whether in the 
case of nutrient scarcity or nutrient excess (Wellen and Hotamisligil 2005). Indeed, obesity is 
currently defined as a state of low grade inflammation (Dandona, Aljada et al. 2004; Cancello 
and Clement 2006) characterized by increased levels of inflammatory markers such as C-reactive 
protein (CRP), interleukin-6, and -18 (IL-6, IL-18), P-selectin, tumor necrosis factor alpha (TNF-
α) and leptin; most of these arising from the expanded adipose tissue mass (Greenberg and Obin 
2006; Tilg and Moschen 2006). This chronic low-grade inflammation is believed to be the origin 
of most of the obesity-associated diseases (Wellen and Hotamisligil 2005; Hotamisligil 2006). 
Macrophages have been identified as the major secretory cells in adipose tissue 
contributing to systemic and local inflammation in obesity (Weisberg, McCann et al. 2003; Xu, 
Barnes et al. 2003). Adipose tissue macrophage (ATM) recruitment is increased dramatically 
(Weisberg, McCann et al. 2003) with the expansion of fat mass comprising up to 50% of adipose 
tissue cells in the obese state. Whereas macrophages are present in the adipose tissue of both lean 
and obese subjects, they differ in number, distribution, phenotype and function. In the lean state, 
resident (Type II) macrophages display an anti-inflammatory phenotype. They are F4/80+, 
CD11c-, MGL1+(Lumeng, DelProposto et al. 2008), express higher numbers of M2 gene 
transcripts such as Il10, Mgl1 and Arg1 (Lumeng, Bodzin et al. 2007),  are dispersed in the 
interstitial space between adipocytes (Cinti, Mitchell et al. 2005) and are believed to have a role 
in preserving adipose tissue (AT) integrity and maintenance. On the other hand, obesity recruited 
(Type I) macrophages, display a pro-inflammatory phenotype (Nguyen, Favelyukis et al. 2007; 
Lumeng, DelProposto et al. 2008) have a high transcript level expression of Tnfa, Il6 and Nos2 
(Lumeng, Deyoung et al. 2007) and are F4/80+, CD11c+, MGL1- (Lumeng, Bodzin et al. 2007; 
Westcott, Delproposto et al. 2009). They form crown-like structures surrounding necrotic-like 
adipocytes and are believed to have a role in the clearance of dying adipocytes (Cinti, Mitchell et 
al. 2005; Murano, Barbatelli et al. 2008).   
 Many factors are capable of inducing macrophage infiltration and activation in 
adipose tissue. Adipocyte death, hypoxia, angiogenesis, T-cell infiltration and certain 
chemokines have all been studied and demonstrated as candidates to promote ATM recruitment 
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(Cinti, Mitchell et al. 2005; Wu, Ghosh et al. 2007; Ye, Gao et al. 2007; Kintscher, Hartge et al. 
2008; Pang, Gao et al. 2008; Rausch, Weisberg et al. 2008; Wang, Wood et al. 2008).  CCL2, 
also known as monocyte chemotactic protein-1(MCP-1), and its receptor, CCR2, are the best 
studied chemokine-ligand receptor pair that promotes macrophage accumulation in white AT. 
Some reports showed a high correlation between CCL2 and CCR2 expression in ATM 
recruitment in obese individuals (Kamei, Tobe et al. 2006; Kanda, Tateya et al. 2006; Weisberg, 
Hunter et al. 2006), however more recent studies failed to show this correlation (Inouye, Shi et 
al. 2007; Kirk, Sagawa et al. 2008).  These data suggest that other factors, probably endogenous 
to fat mass and related to obesity, play a major role in ATM recruitment. 
Leptin plays a major role in both innate and adaptive immunity (La Cava and Matarese 
2004). The long leptin receptor isoform (LepRb), responsible for leptin’s physiological activities 
(Tartaglia, Dembski et al. 1995; Baumann, Morella et al. 1996), has been identified on most 
immune cells including monocytes and macrophages (Raso, Pacilio et al. 2002; Tian, Sun et al. 
2002; Caldefie-Chezet, Poulin et al. 2003; Matarese, Moschos et al. 2005; Mattioli, Straface et 
al. 2005; Papathanassoglou, El-Haschimi et al. 2006; Batra, Okur et al. 2009). Some have 
suggested that leptin initiates the recruitment and differentiation of macrophages in the AT (Xu, 
Barnes et al. 2003). Leptin is a potent chemoattractant for monocytes and macrophages in vitro 
(Gruen, Hao et al. 2007). It increases the expression of adhesion molecules in epithelial cells and 
it enhances diapedesis of monocytes through an epithelial layer (Curat, Miranville et al. 2004). In 
addition, leptin induces a pro-inflammatory or Th1 cytokine secretion by macrophages and 
monocytes (Lord, Matarese et al. 1998) while inhibiting a Th2 response. Indeed, leptin deficient 
(ob/ob) and leptin receptor-deficient (db/db) mice exhibit less macrophage infiltration in AT than 
would be expected for their body weight (Weisberg, McCann et al. 2003; Xu, Barnes et al. 
2003).  
Since human obesity is often characterized by a hyperleptinemic state, we tested the role 
of the LepRb on white blood cells in the recruitment of ATMs. We demonstrated that the 
absence of the long leptin receptor isoform ameliorates the expression of the obese phenotype as 
indicated by attenuated weight gain, a higher insulin sensitivity index and decreased 
inflammation in the adipose tissue of diet-induced obese (DIO) mice. 
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 Materials and Methods 
Animals- Five-week old wild type (WT) male C57BL/6J mice, and 10-week old male WT 
and db/db mice on the C57BL/6J background, were purchased from Jackson Laboratories (Bar 
Harbor, ME). Animals were housed individually in sterile micro-isolators under specific 
pathogen-free conditions at 30-40% controlled humidity and a 12-hour light/dark cycle. Animals 
were allowed a one week adaptation period prior to any intervention. All animal procedures were 
performed according to the Guide for the Care and Use of Laboratory Animals with the approval 
and monitoring of the Institutional Animal Care and Use at Kansas State University and the 
University of Kansas-Medical Center. 
Materials and Reagents- Primary labeled monoclonal anti-mouse CD3, B220 F4/80 and 
CD11b and their respective isotype controls were purchased from eBioscience (San Diego, CA). 
For immunohistochemistry, primary labeled monoclonal anti-mouse antibodies against MGL1 
and F4/80 and their respective isotype controls were purchased from AbD Serotec (Raleigh, 
NC). Anti-mouse CCR2, its secondary (goat anti-rabbit IgG) antibody and isotype control 
antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).  
Lethal Total Body Irradiation and Bone Marrow Transplantation (BMT) - Thirty-six, 6-
week old WT mice were irradiated with a single 10 Gy dose from a 137Cs γ source. Bone marrow 
cells were collected from eleven-week old WT and db/db mice by flushing long bones (femora, 
tibiae and humeri) with sterile PBS containing 50 µg/ml gentamycin (Sigma-Aldrich, St. Louis, 
MO). Recipient mice were each reconstituted with 2x107 bone marrow cells by intravenous 
injection through the retro-orbital sinus. There were 16 mice in each WT bone marrow and db/db 
bone marrow treatment groups.  Four irradiated mice were not reconstituted and used to confirm 
irradiation effectiveness. Reconstituted mice were housed in laminar flow isolators and received 
acidified water supplemented with 100 mg/l neomycin and 10 mg/l polymyxin B sulfate 1 week 
prior and 2 weeks post-irradiation according to an established protocol (Lim, Timmins et al. 
2008).  Thereafter, acidified water was provided for all mice. Mice were monitored for 
symptoms of radiation sickness and mortality. Reconstituted mice received an irradiated normal 
fat diet (NFD, D12450B, 10% kcal from fat, Research Diets Inc., New Brunswick, NJ) for six 
weeks at the end of which reconstitution was assessed. At that time, mice were moved to 
standard housing where half of each bone marrow reconstitution group was randomly assigned to 
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the NFD or switched to a high fat diet (HFD, D12492, 45 kcal% from fat, Research Diets Inc.) 
for an additional sixteen weeks. Sixteen additional age- and gender-matched WT mice received 
the same treatments and randomization without the irradiation and transplantation and served as 
the irradiation effect controls for the study. The study design is outlined in Figure 2.1. 
             
           
Figure 2.1 Diagram of the study 
   BM= bone marrow, LepR-/-= leptin-receptor deficient 
 
Assessment of Irradiation and Transplantation Effectiveness- Blood was collected 
through the retro-orbital sinus from non-transplanted mice three days post-irradiation to confirm 
that mouse hematopoietic systems were destroyed by radiation treatment. Blood was collected 
also from age, strain and gender-matched WT non-irradiated mice for comparison. Red blood 
cells were lysed in hypotonic buffer, centrifuged and the resulting pellet was assessed by flow 
cytometry (FACSCalibur, Becton Dickson, San Jose, CA) for the presence of CD3, B220, F4/80 
and Ly6G to determine the percentages of T-cells, B-cells, macrophages and neutrophils. Blood 
was collected from all transplanted mice six weeks post-irradiation and T-cell and B-cell 
percentages were assessed using similar techniques. 
Anthropometric and Serological Measurements- Body weight and food intake were 
measured weekly. Blood was collected at 0, 8 and 16 weeks after the dietary intervention.  Prior 
to each collection, mice were fasted for 4 hrs, anesthetized with isoflurane and eyes were treated 
with one drop of proparacaine hydrochloride (0.5%). Approximately 0.4 ml of blood was 
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collected from the retro-orbital sinus of each mouse. Serum was separated from clotted blood 
and stored at -80°C. Fasting blood glucose was measured at each blood withdrawal using a 
digital glucometer (Contour Blood Glucose Monitoring System, Bayer, Mishawaka, IN). The 
homeostasis model assessment of insulin resistance (HOMA-IR) was calculated using the 
following formula: fasting blood glucose (mg/dl) × fasting insulin (µU/ml)/405. 
Serum Cytokine/Adipokine Analysis- Insulin, leptin, MCP-1, IL-6 and TNF-α were 
measured in serum from fasted mice by fluorescent immunoassay using a Milliplex MAP kit for 
mouse serum adipokine (Millipore, St. Charles, MO) according to the manufacturer’s 
instructions. The samples were processed on a Luminex 100, and results were analyzed with 
MasterPlexQT software (MiraiBio, South San Francisco, CA, USA). 
Adipose Tissue Digestion, Adipocyte Collection and ATM Sorting- Epididymal, inguinal, 
mesenteric and retroperitoneal fat pads were dissected from all mice, weighed, and were 
collectively constituted the total dissectible fat. Epididymal and inguinal fat pads were finely 
minced and added to Krebs Ringer buffer (KRB) solution supplemented with 1 mg/ml type II 
collagenase (Sigma-Aldrich). Homogenates were incubated at 37°C for 10 minutes and then 
moved to a shaking incubator for an additional 40 minutes incubation at 37°C with agitation at a 
speed of 0.1 x g. The cell suspension was filtered through nylon cell strainers (100 µm; Fisher 
Scientific, Pittsburg, PA) and centrifuged at 300 x g for 1 minute. Floating adipocytes were 
collected and washed with KRB and RNA was extracted using TRI reagent (MRC, Cincinnati, 
OH) similar to the method described by Chomczynski et al. (Chomczynski and Sacchi 1987). 
The stroma-vascular fraction (SVF) pellet was washed twice with KRB. Cells were blocked with 
50% normal goat serum in PBS for 30 minutes at 4°C and incubated with F4/80 and CD11b 
antibodies for 1 hour at 4°C followed by 2 washes in PBS. ATMs were then sorted by co-
expression of F4/80 and CD11b using a MoFLO XDP cell sorter (Becton Dickinson, Franklin 
Lakes, NJ). Double positive cells were sorted directly into TRI reagent for RNA extraction. 
RNA Isolation and Gene Expression Quantification- RNA was extracted from adipocytes 
and sorted macrophages as described above. RNA was purified and DNAse treated using 
E.Z.N.A Total RNA kit and RNase Free DNase Set (Omega Bio-Tek, Norcross, GA). RNA 
quality was assessed by microfluidics (Agilent Bioanalyser, Agilent Technologies, Bracknell, 
UK) and RNA was considered of acceptable quality if the RNA integrity number (RIN) was 
equal or higher than 8.  RNAs were reverse transcribed into cDNA with the RT² First Strand 
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cDNA Kit (SABiosciences, Frederick, MD). cDNA of transcripts of interest were assessed by 
real-time PCR using a customized SYBR Green real-time PCR detection superarray from 
SABiosciences (Frederick, MD). The superarray format was a 96-well, 12 genes/8 samples 
template. Sequences coding for tnfa, il6, Ccl2, Ccr2, mgl1, lep, lepr, adipoq and Pparg were 
targeted by the assay. Actb (β-actin) was used as the internal standard for normalization and RT 
and genomic DNA were assessed for each sample as quality controls. Fluorescence was assessed 
on a real-time thermal cycler (iCycler, Bio-Rad, Hercules, CA). Results were calculated using the 
2– CT method as directed by the superarray manufacturer protocol and expressed in fold 
increase/decrease of the gene of interest in all groups vs. the non-irradiated NFD group.  
Immunohistochemistry and Adipose Tissue Morphology- Samples from epididymal fat 
were fixed in 10% formaldehyde for 24 hours prior to embedding in paraffin. A total of 4 
sections, 100 µm apart, were cut per mouse tissue.  Each section was 10 µm thick. Sections were 
deparaffinized with xylene and decreasing concentrations of ethanol. Antigen retrieval was 
performed by immersing the slides in citrate buffer (10 mM citric acid, 0.05% Tween20, pH 6.0) 
for 30 minutes at 90-95°C.  Non specific binding was blocked by incubating the slides for 30 
minutes in homologous serum at 37°C. Three sections per mouse were incubated overnight with 
anti-mouse F4/80, MGL-1 and CCR2 antibodies and 1 section with the respective isotype 
controls at 4°C. The CCR2 secondary antibody was added and slides were incubated for 1 hour 
at room temperature.  Non-labeled sections were subjected to the same treatment with no 
antibody added to determine the background autofluorescence level of the adipose tissue. 
Microscope light settings were set to minimize autofluorescence and fluorescence from non-
specific antibody binding. Samples were examined using a laser scanning confocal microscope 
(Zeiss LSM 5 PASCAL, Zeiss, Thornwood, NY). Aggregates of macrophages surrounding a 
single adipocyte known as crown-like structures (CLS, (Cinti, Mitchell et al. 2005) were 
identified by the presence of F4/80 and CCR2 on cells forming the “crowns” surrounding 
adipocytes. Adipocyte size was obtained from perimeter tracings using Image J software. Fat cell 
number was calculated per cm2 of adipose tissue in each field.  
Liver pathology- Entire livers were dissected from each animal and weighed. 
Approximately, a 200 mg liver sample was fixed in 10% formaldehyde for 24 hours and 
embedded in paraffin. Deparrafinized 10 µm sections were H&E stained. Samples were coded 
and scored by two blinded observers for microvesicles (lipid droplets with visible nuclei), 
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macrovesicles (lipid droplets with no visible nuclei) and structure (irradiating structure from 
visible blood vessels) for 2 sections per mouse. The rating scale ranged from 1 to 3, with 1 being 
the least amount of micro- and macrovesicules and the most conserved structure and 3 the 
highest amount of micro-and macrovesicules with a disrupted structure of hepatocytes. 
Statistical Analysis- Anthropometric and serologic data were analyzed as an analysis of 
covariance model (ANCOVA) with a 2 (diet) x 3 (irradiation) factorial treatment structure in a 
completely randomized design. Initial weight was the covariate and was used to calculate 
adjusted treatment means. When the diet x Irradiation interaction was significant contrasts on the 
adjusted diet x irradiation means were performed to test whether the change in responses 
between HFD and NFD is the same magnitude between the three irradiation treatments. The 
ANCOVA analysis was performed using the GLM procedure in SAS (SAS Institute Inc. Cary, 
SC). For all other response variables (for which adjustment for initial weight was not necessary), 
regular analysis of variance (ANOVA) was performed and differences between the six 
treatments were calculated using the LSD method. The ANOVA analysis was performed using 
SPSS software (SPSS Inc. Chicago, IL). For all analyses, statistical significance was considered 
at p<0.05.  
 Results 
 Total Body Irradiation and BMT  
Mice were irradiated and reconstituted with bone marrow from WT and db/db donors to 
test the hypothesis that leptin, through its long receptor, plays a role in macrophage recruitment 
and adipose tissue inflammation in obese animals. Unreconstituted mice had no (<1% of normal) 
circulating leukocytes, T-cells, B-cells, neutrophils or macrophages by day 3 post-irradiation 
(data not shown). Therefore, the residual recipient leukocytes contamination was minimal in 
these radiation chimeras. At 6 weeks post-transplantation, irradiated mice were completely 
reconstituted. There were no statistical differences in either B-cell percentages (56.1 ± 10.3% vs. 
51.8 ± 8.9%) or T-cells percentages (16.3 ± 3.4% vs. 17.6 ± 2%) between transplanted and non-
irradiated control mice, respectively. Therefore, mice were considered immunosufficient, moved 
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to standard facilities, and divided into NFD and HFD treatment groups as described in the 
Materials and Methods (Figure 2.1). 
 Mice Reconstituted with Leptin Receptor-Deficient Bone Marrow were Resistant to 
Weight and Fat Mass Gain after 16 Weeks HFD  
Non-irradiated and reconstituted irradiated mice were weighed and food intake was 
assessed weekly to test whether transplantation with leptin receptor-deficient bone marrow or 
whole body irradiation affects weight gain.  Fat pads were dissected and weighed at study 
termination. Six weeks after bone marrow reconstitution, irradiated mice weighed significantly 
less that the non-irradiated controls (23.9 ± 1.2 vs. 28.3 ± 0.9 g respectively, p<0.0001). There 
were no signs of malabsorption such as diarrhea or bloody stools in any of the mice. Due to the 
difference in starting weights, all comparisons were made after adjusting for baseline weight 
using ANCOVA (Raubenheimer 1992).  We assessed the effect of both diet (HFD vs. NFD) and 
irradiation regimen (Irr-WT, Irr-db and Non-Irr) and the interaction of both (Diet x Irradiation). 
Both the model and the Diet x Irradiation interaction were significant for weight and fat mass 
parameters (p<0.05, Figure 2.2). This shows that there is combined effect of both diet and 
irradiation on weight and fat mass beyond the added effect of diet and irradiation alone. 
Contrasts analysis (Abdi & Williams 2010) was performed, in case of a significant model, to 
assess whether the measured difference between HFD and NFD is statistically different between 
the 3 irradiation treatment groups (Non-Irr, Irr-WT and Irr-db). The difference in mean adjusted 
final weights between HFD and NFD was smaller in the Irr-db group (32 ± 1g vs. 31 ± 1g) 
compared to either the Irr-WT (35 ± 1 vs. 31 ± 1, p<0.05) or the Non-Irr groups (35.5 ± 1 vs. 28 
± 1, p<0.002) (Figure 2.2-A). Significant differences were not observed in weight and weight 
change between Non-Irr and Irr-WT groups (p>0.1). The same was seen in adjusted total 
dissectible fat, epididymal and inguinal fat depots where HFD feeding had the least effect in the 
Irr-db group compared to Irr-WT (p>0.05) and Non-Irr groups (p<0.02) (Figure 2.2-D, E, F). 
Differences in weight and fat mass in the different irradiation groups were not a result of caloric 
intake given that no statistical difference in overall caloric intake was calculated between the 
different treatment groups (p>0.05, Figure 2.2- C). These data suggest that replacing the bone 
marrow with leptin receptor-deficient cells provided some resistance to high fat diet-induced 
weight and fat mass gain.   
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Figure 2.2 Mice reconstituted with leptin receptor-deficient bone marrow (Irr-db) have minimal difference between 
HFD and NFD in weight (A), total weight change (B), total dissectible fat (D), epididymal (E) and inguinal fat pads 
(F) compared to Non-Irr and Irr-WT mice.  
Analyses are done for means adjusted for initial weight using 2 way interaction (Diet and Irradiation) and comparing 
mean differences within irradiation groups using contrast analysis (see Materials and Methods). Groups with 
different letters have means differences between HFD and NFD significantly different (p<0.05). 
Adipocyte Size Increased in Irr-db Mice on HFD without Change in Fat Pad Weight 
Adipose tissue morphology in epididymal fat pads of all mice was examined to determine 
if the smaller weight and fat mass gain in Irr-db mice was secondary to adipocyte dysregulation.  
There was a decrease in the number of adipocytes/cm2 of tissue (31.3 ± 5.2 vs. 19.2 ± 3.3 and 
45.6 ± 5.5 vs. 24.9 ± 5.1, p<0.05) and a corresponding increase in adipocyte mean size (5.2 ± 1.6 
vs. 2.6 ± 0.4 and 3.7 ± 1.2 vs. 1.8± 0.2, p<0.05) in Non-Irr and Irr-db HFD groups, respectively, 
compared to their NFD controls (Table 2.1 and Figure 2.3).  
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Figure 2.3 A HFD leads to an increase in adipocyte size in all mice.   
Deparaffinized epididymal fat sections (10µm thick) visualized with a confocal microscope at 200 magnification. 
Representative picture from each experimental group. A,B,C HFD non-irradiated, irradiated with WT bone marrow 
and irradiated with db/db bone marrow. D,E,F NFD non-irradiated, irradiated with WT bone marrow and irradiated 
with db/db bone marrow 
 
             
 
Figure 2.4 A HFD in Non-Irr and Irr-db mice led to an increase in the percentage of larger adipocytes.  
Adipocyte size distribution by area size (µm2) measured using Image J. Thirteen to fifteen photomicrograps were 
examined per mouse. 
27 
 
Table 2.1 Epididymal adipose tissue morphology, adipocyte mean size and number per group.  
Parameter  
Non-Irradiation 
HFD       NFD 
Irradiated-WT 
HFD          NFD 
Irradiated-db 
HFD          NFD 
 
p-value*  
Epididymal fat pad (g)  2.3 ± 0.3a,# 1.1 ± 0.2d 1.4 ± 0.4b,# 0.5 ± 0.1d,e 0.9 ± 0.4b 0.5 ± 0.0e 0.001  
Number of 
adipocytes/cm2 (x103)  
19 ± 3a,# 31 ± 5d 32 ± 7b 40 ± 3d,e 25 ± 5a,b,# 46 ± 5e 0.0001  
Mean adipocyte area 
(µm2) (x103)  
5.2 ± 1.6a,# 2.6 ± 0.4 2.7 ± 0.6b 2.0 ± 0.2 3.7 ± 1.2a,b,# 1.8 ± 0.2 0.001  
*p-value between groups as per ANOVA 
a,b &d,e groups with same superscript are not statistically different as per LSD at p<0.05 (a,b for HFD groups and d,e for NFD groups). #statistically different 
from its NFD group as per LSD. 
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Both Non-Irr and Irr-db groups on HFD had a larger fat cell size distribution compared to 
their NFD controls (Figure 2.4). This trend was less pronounced in the Irr-WT group which had 
the fewest number of adipocytes larger than 8000µ2 (Figure 2.4). Hence, irradiation did not 
compromise the ability to store, synthesize or take up triacylglycerol (TAG). In particular, the 
Irr-db group responded to the HFD feeding in a similar fashion as the Non-Irr group as judged by 
their increased adipocyte size.  Although Irr-db mice had increased numbers of large adipocytes 
with a significant increase in mean adipocyte area when on a HFD compared to Irr-db on NFD, 
the total epididymal fat pad weight did not differ significantly between Irr-db HFD and NFD 
groups (0.9 ± 0.4 vs. 0.5 ± 0.04 g, p>0.05) (Table 2.1). On the other hand, no significant 
difference in adipocytes size and number per area was measured between HFD and NFD in the 
Irr-WT treatment group. However, epididymal fat pads weights were significantly higher in the 
HFD group compared to its NFD control (1.4 ± 0.4 vs. 0.5 ± 0.1 g, p<0.01, Table 2.1). These 
data suggest that adipose tissue in the Irr-db mice responded differently to HFD than the Irr-WT 
group.  
 Liver Histology Shows no Increase in Ectopic Fat Deposition in Irradiated Mice  
Fat is stored in the liver when the adipose tissue fails to take up fatty acids efficiently 
secondary to adipocytes dysfunction. Liver steatosis was measured in all mice to determine 
whether adipocyte fatty acid uptake was altered by irradiation.  The lower fat mass gain in the 
Irr-db mice on a HFD would be expected to lead to ectopic fat deposition in the liver if it were 
functioning normally. All groups accumulated some fat in the liver, and all mice on a HFD had a 
higher fat content than their NFD counterparts as shown by the presence of large enucleated fat 
droplets or macrovesicules (Figure 2.5).   
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Figure 2.5 Irradiated mice on HFD show less fat deposition in the liver compared to the non-irradiated group. 
Deparaffinized liver sections (10µm sections) observed under inverted microscopy in brightfield at 200 
magnification.  A, B, C: HFD non-irradiated, irradiated db, irradiated WT respectively. D, E, F: NFD non-irradiated, 
irradiated db, irradiated WT respectively. Red arrows point at examples of macrovesicules, green arrows at 
examples of microvesicules and blue arrows at blood vessels. 
 
Liver weights, and liver weights as percentage of the total body weight were highest in the Non-
Irr group on HFD compared to the 2 irradiated groups on HFD (2.1 ± 0.6 vs. 1.3 ± 0.3 and 1.2 ± 
0.2 g;  4.9 ± 0.6 vs. 4.1 ± 0.6 and 4.3 ± 0.4 % respectively, p<0.05, Table 2.2). Structure and 
microvesicules were not different in any of the groups (p>0.05).  However, significantly more 
macrovesicules, a measure of more severe steatosis, were observed in the Non-Irr HFD group 
compared to its NFD counterparts (2.44 ± 0.6 vs. 1.0 ± 0.0, p<0.05, Table 2) and compared to the 
both Irr-WT and Irr-db on HFD (2.44 ± 0.6 vs. 1.75 ± 0.6 and 1.81 ± 0.7 respectively, p<0.05, 
Table 2).  Irr-db on HFD also had a higher score for macrovesicules compared to its NFD control 
(1.81 ± 0.7 vs. 1.06 ± 0.2, p<0.05, Table 2.2). These data show that that there was no 
compensatory uptake of fatty acids in the livers of irradiated mice. 
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Table 2.2 Liver steatosis parameters 
Parameter  
Non-Irradiation 
HFD       NFD 
Irradiated-WT 
HFD          NFD 
Irradiated-db 
HFD          NFD 
 
p-value*  
Liver  weight(g)  2.1 ± 0.6a,# 1.6 ± 0.2d 1.3 ± 0.3b 1.4 ± 0.2d,e 1.2 ± 0.2b 1.3 ± 0.2e 0.001 
Percentage liver 
weight/body weight (%)  
4.9 ± 0.6a 4.8 ± 0.4 4.1 ± 0.6b,# 5.1 ± 0.4 4.3 ± 0.4b,# 5.1 ± 0.5 0.001 
Microvacuoles score& 2.7 ± 0.5 2.3 ± 0.6 2.4 ± 0.8 2.4 ± 0.7 2.7 ± 0.4 2.6 ± 0.6 NS 
Macrovacuoles score 2.4 ± 0.6a,# 1.0 ± 0.0 1.7 ± 0.6b 1.5 ± 0.5 1.8 ± 0.7b,# 1.1 ± 0.2 0.001 
Structure  score 1.6 ± 0.7 1.3 ± 0.5 1.6 ± 0.6 1.7 ± 0.6 1.7 ± 0.6 1.2 ± 0.4 NS 
*p-value for ANOVA between all groups 
a,b &d,e groups with same superscript are not statistically different as per LSD at p<0.05, (a,b for HFD groups and d,e for NFD groups). #statistically different 
from its NFD group as per LSD. &The overall score was calculated as the mean value from 2 observers rating 5-6 mouse samples per group (2 slides per 
mouse). The scoring system was from 1 to 3, number 1 for the least amount of microvacuoles, macrovacuoles and the best conserved structure and 3 for the 
highest presence of microvacuoles, macrovacuoles and the disrupted structure.   
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 Gene Expression in Irr-db Adipocytes Shows a Blunted Increase in Inflammatory 
Genes Compared to Irr-WT Adipocytes  
Adipose tissue during obesity is characterized by an increase in inflammatory gene 
expression. Adipocyte transcript expression was calculated for relevant genes in obesity-
associated inflammation to see if leptin receptor expression had an impact on the level of 
inflammation in adipocytes. Epididymal adipocytes were analyzed and gene transcript levels 
were assessed using a customized superarray as described in the Materials and Methods. Non-Irr 
mice on the NFD were used as controls for calculations of fold changes for the specific genes of 
interest since they constitute age, gender and strain-matched counterparts for all groups. TNF-α 
and IL-6 were increased in the Non-Irr on HFD compared to the NFD control (41 fold, p<0.05, 
and 6 fold respectively, Table 2.3).  In the Irr-WT on HFD, both TNF-α and IL-6 were increased 
(4 and 3 fold respectively, Table 2.3) whereas in the Irr-db group on HFD group this increase 
was only by 2 fold for both (Table 2.3). Leptin gene expression was increased 2 fold in the HFD 
groups except for the Irr-db group consistent with the adipose tissue data showing no increase in 
fat mass in the group on HFD. Adiponectin, an anti-inflammatory adipokine (Mandal, Pratt et 
al.), was significantly decreased in the Non-Irr group on the HFD (2 fold, p<0.05) with no 
change in the other groups. CCL2 and its receptor CCR2 were both upregulated in Non-Irr and 
Irr-WT groups on HFD (5 to 8 fold increase and 3 to 5 fold increase respectively, Table 2.3). No 
change was measured in the Irr-db groups (Table 2.3). Peroxisome proliferator-activated receptor 
gamma (PPARγ) involved in adipogenesis and lipid uptake in adipocytes (Barak, Nelson et al. 
1999; Rosen, Sarraf et al. 1999) was upregulated in all irradiation groups regardless of the 
dietary allocation (2 to 3 fold increase, Table 2.3). These data suggest that replacing the bone 
marrow with leptin receptor-deficient cells led to an attenuation of inflammatory and insulin 




Table 2.3 qRT-PCR-based fold differences in mRNA abundance in epididymal fat pad adipocytes in control (Non-
Irr on NFD) vs.all other groups 
 
*p<0.05 , **p<0.01, ***p<0.001 vs Non-Irr NFD group 
 #No change was assumed if fold change was equal or less than 1.5 
 Irradiated Mice with db/db Bone Marrow have Less Inflammatory ATMs and Exhibit 
Fewer CLS in their Adipose Tissue  
Obesity is associated with increased pro-inflammatory ATMs. These ATMs form CLS 
surrounding dying adipocytes (Cinti, Mitchell et al. 2005). We tested whether the deficiency of 
LepRb in monocytes/macrophages affected the inflammatory phenotype of adipose tissue under 
a HFD. Cells in the SVF from collagenase-digested fat pads were labeled with F4/80 and CD11b 
antibodies to identify double positive macrophages by FACS analysis. No difference in 
percentage F4/80+/CD11b+ ATMs was measured between HFD and NFD in either Irr-WT or Irr-
db groups (ANOVA, p>0.05, Table 2.4). As expected, the percentage ATMs in epididymal fat 
was more than 3-fold higher compared to that in inguinal fat pads (average 31 ± 3 vs. 8 ± 2, p< 
0.0001, Table 2.4) with no statistical difference between any of the groups. 
These data suggest that replacing the bone marrow with leptin receptor-deficient cells 
shifted ATMs towards an anti-inflammatory phenotype in DIO mice. 
Gene  Non-Irr HFD Irr-WT-HFD Irr-WT NFD Irr-db HFD Irr-db NFD 
 Tnf  ↑41* ↑4 ↑2 ↑2 No change# 
Il6  ↑7 ↑3 ↑3 ↑2 No change 
 Lep  ↑2 ↑2 No change No change No change 
lepr  ↑3 ↑2 ↑5 No change ↑2 
 Ccl2  ↑5** ↑3 ↑2 No change No change 
Ccr2  ↑8 ↑5* ↑3 No change No change 
Mgl1  ↑4*** ↑2 ↑2 No change No change 
Pparg  No change ↑2 ↑3 ↑2* ↑2* 
Adipoq  ↓2 ↑2 No change No change No change 
Actb No change No change No change No change No change 
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Table 2.4 Percentage sorted CD11b+/F4/80+ macrophages from epididymal and inguinal fat depots of all mice. 
Parameter  
Non-Irradiation 
HFD       NFD 
Irradiated-WT 
HFD          NFD 
Irradiated-db 
HFD          NFD 
p-value* 
Epididymal fat  34 ± 4& 26 ± 2 33 ± 7 32 ± 10 33 ± 7 28 ± 8 NS 
Inguinal fat  10 ± 3.5 6 ± 4 10 ± 7 6 ± 4 10 ± 10 6 ± 4 NS 
*ANOVA done for each fat pad between all groups 
& p,0.05 between HFD and NFD group within same irradiation group as per student t-test
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Inguinal fat contained fewer macrophages than epididymal fat and displayed no increase 
in inflammatory or metabolic genes where animals received a HFD. Therefore, we determined 
macrophage localization and phenotype only in the epididymal adipose tissue using 
immunohistochemistry (IHC). Deparaffinized epididymal fat sections were probed for F4/80 as 
the general marker for macrophages, CCR2 as the marker for Type I or pro-inflammatory 
macrophages and Mgl1 as the marker for Type II or anti-inflammatory macrophages using a 
laser scanning confocal microscope.  The Non-Irr group showed the highest amount of labeling 
for both F4/80 and CCR2 antibodies. Mice receiving the HFD had increased labeling of F4/80 
and CCR2 compared to NFD groups in both the Non-Irr and Irr-WT groups. Mice in the Irr-db 
group showed no labeling for CCR2 in either the HFD or NFD groups. All F4/80+ macrophages 
were Mgl1+ and CCR2- (Figure 2.6). These data demonstrate that ATMs in irradiated mice on a 
HFD display a pro-inflammatory CCR2+ phenotype after reconstitution with WT BM but an 
anti-inflammatory Mgl1+ phenotype after reconstitution with db/db BM.  To confirm that ATMs 
in Irr-db mice on HFD were different from WT reconstituted chimeras we examined CLS in 
epididymal fat pads. The number of CLS/section in Irr-db mice on HFD was significantly less 
than the number in both Irr-WT mice on HFD (0.2 ± 0.5 vs. 0.6 ± 0.8, p<0.05, Figure 2.7) and 




    
Figure 2.6 Irr-db mice on a HFD (panels E) have a prevalence of CCR2-/ Mgl1+ anti-inflammatory F/4/80+ 
macrophages.   
Paraffin-embedded epididymal fat sections (10µm sections) observed under laser scanning confocal microscope at 




Figure 2.7 Irr-db mice on HFD have fewer crown-like structures (CLS) in epididymal fat pads.  
Quantification of CLS/field in epididymal fat of all experimental mice. *Significance as per LSD within same diet 
group, p>0.05. # Significance as per LSD within same irradiation group, p>0.05 
Irr-db Mice have an Improved Systemic Metabolic Profile  
Diet-induced obesity leads to systemic metabolic and inflammatory disturbances. We 
measured fasting serum levels of TNF-α, IL6, MCP-1, leptin, insulin and glucose in all mice at 0, 
8 and 16 weeks of the study. No differences were observed in IL-6, TNF-α or MCP-1 amongst 
any of the groups at any measured time point (data not shown).  Paralleling fat mass data, leptin 
levels were highest in the Non-Irr HFD group compared to Irr-WT HFD and Irr-db HFD (40 ± 7, 
22 ± 8 and 12 ± 9 ng/ml respectively, p<0.01, Figure 2.8). Fasting insulin and the HOMA-IR 
index ere measured to assess glucose metabolism in all experimental mice. Both measures were 
highest in the Non-Irr HFD group compared to both Irr-WT HFD and Irr-db HFD groups (4 ± 2 
ng/ml vs. 2 ± 0.5 ng/ml and 1.3 ± 0.2 ng/ml for insulin respectively and 48 ± 32 vs. 22 ± 6.5 and 
16 ± 5 for HOMA-IR respectively, p<0.01, Figure 2.8). Contrast analysis as described in 
Materials and Method was performed for these 2 parameters at week 16 to test if the magnitude 
change between HFD and NFD was similar across the 3 groups. The Irr-db treatment group had 
the smallest increase in these 2 parameters and a blunted response after a HFD with the 
difference between HFD and NFD almost reaching significance compared to that in the Non-Irr 
group (2 vs. 0.2 ng/ml difference for insulin, p=0.07 and 26 vs. 4 unit difference for HOMA-IR, 
p=0.06, Figure 2.8). No significant difference was measured between Non-Irr and Irr-WT 
(Figure 2.8).                       
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Figure 2.8 Mice reconstituted with leptin receptor-deficient bone marrow (Irr-db) have minimal difference between 
HFD and NFD in serum leptin (A), serum insulin (B), and HOMA-IR (C) compared to Non-Irr and Irr-WT mice. 
 Fasting serum levels of leptin and insulin and measures of HOMA-IR at 0, 8 and 16 weeks of dietary treatment. Full 
lines represent HFD groups, dotted lines are for NFD groups. Black (♦) for Non-Irr, dark grey () and light grey 
(•) for Irr-db. Difference between HFD and NFD significantly different in Irr-WT versus Irr-db at *p<0.05. &p=0.07,  





Obesity induces a state of low grade inflammation arising from an inflamed adipose 
tissue characterized by the presence of inflammatory macrophages (Hotamisligil, Shargill et al. 
1993; Weisberg, McCann et al. 2003; Xu, Barnes et al. 2003).  The factors behind this increased 
recruitment are not completely defined, though many factors have been investigated. However, 
none of these factors are exclusively responsible for this process (Weisberg, Hunter et al. 2006; 
Kintscher, Hartge et al. 2008; Pang, Gao et al. 2008; Rausch, Weisberg et al. 2008; Bertola, 
Deveaux et al. 2009; Kosteli, Sugaru et al. 2010; Kim, Jeong et al. 2011). We hypothesized that 
leptin plays an important role in the recruitment of inflammatory macrophages and the 
exacerbation of the resulting inflammatory and metabolic disturbances in obesity. We 
successfully constructed chimeric mice that lacked the LepRb on circulating leukocytes in order 
to test our hypothesis. This allowed us to examine the impact leptin has on the recruitment of 
ATMs in a DIO model. We concluded that the lack of LepRb expression on bone marrow cells 
attenuates the inflammatory profile of the adipose tissue and alleviates weight and fat mass gain 
in DIO mice. 
The lack of leptin signaling on monocytes/macrophages was accompanied by 
significantly less CLS in epididymal fat of DIO mice. These data suggest that the absence of 
LepRb was diminishing the inflammation in the adipose tissue because CLS numbers correlate 
with adipose tissue inflammation (Strissel, Stancheva et al. 2007; Murano, Barbatelli et al. 2008). 
This conclusion is supported by a prevalence of Mgl1+ macrophages (assessed by qRT-PCR and 
indirect immunofluorescence) with few CCR2+ macrophages in epididymal fat depot. Mgl1 is 
associated with macrophages in the pre-obese fat and CCR2 is associated with pro-inflammatory 
macrophages (Lumeng, Bodzin et al. 2007). Normal mice and mice reconstituted with WT bone 
marrow had more CCR2+ macrophages when fed a HFD. These molecular expression patterns 
are consistent with the description of macrophages in adipose tissue of obese and non-obese 
animals (Lumeng, Bodzin et al. 2007; Lumeng, Deyoung et al. 2007; Lumeng, DelProposto et al. 
2008).  These data are also consistent with observations that leptin induces a pro-inflammatory 
phenotype in T-cells (Lord, Matarese et al. 1998) and primes macrophages to secrete 
inflammatory cytokines in septic conditions (Shapiro, Khankin et al. 2010).  In addition, we and 
others have demonstrated that leptin is a potent chemoattractant for monocytes/macrophages 
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(Curat, Miranville et al. 2004; Gruen, Hao et al. 2007) and it is a major chemokine in adipocyte 
conditioned medium (Chapter 4). Although the chimeric mice had a decreased inflammatory 
phenotype in ATMs after a HFD as measured by CLS numbers and Mgl1+/CCR2- ATMs, we 
were not able to find a difference in the percentage F4/80+/CD11b+ sorted macrophages in the 
epididymal or inguinal SVF between treatment groups. Only normal non-irradiated mice on HFD 
had more F4/80+/CD11b+ macrophages in their epididymal fat compared to their NFD controls. 
It is possible that the isolation procedure with collagenase affected our ability to measure 
accurately surface expression of these molecules (Ruan, Zarnowski et al. 2003). Our data 
indicate that leptin contributes to the M1 to M2 switch of ATMs in DIO mice though more 
studies are warranted to assess the role of leptin in the actual recruitment process.  
Mice with leptin receptor deficient bone marrow had minimal increase in adipocytes 
inflammatory genes transcript levels. TNF-α and Il-6 adipocyte gene transcript levels were 
increased in all mice on HFD but mice with leptin receptor deficient bone marrow had only a 2 
fold increase in these transcript levels compared to a 4 fold increase in WT transplanted mice. 
These data also suggest that LepRb has an impact on macrophage activation. There is cross talk 
between macrophages and adipocytes, with each cell type affecting metabolism and secretory 
function of the other (Suganami, Tanimoto-Koyama et al. 2007; Yamashita, Soga et al. 2007; 
Xie, Ortega et al. 2010).  The prevalence of anti-inflammatory macrophages in the adipose tissue 
of leptin receptor-deficient bone marrow mice might explain the attenuated inflammatory profile 
of adipocytes in this model.  The local increase in TNF-α directly contributes to insulin 
resistance at the adipose tissue level through suppression of glucose transporter GLUT4 gene 
expression (Hauner, Petruschke et al. 1995; Xie, Ortega et al. 2010), induction of serine 
phosphorylation of insulin receptor substrate 1 (Hotamisligil, Peraldi et al. 1996) and stimulation 
of lipolysis in adipocytes (Feingold, Doerrler et al. 1992).   
In addition to its role in promoting macrophage recruitment in obesity, CCL2 induces 
insulin resistance in an autocrine fashion on adipocytes by decreasing insulin-stimulated glucose 
uptake (Sartipy and Loskutoff 2003; Weisberg, Hunter et al. 2006). Though, we did not measure 
any of the downstream insulin resistance markers in fat tissue, both CCL2 and CCR2 gene 
transcript levels were increased in adipocytes following a HFD in all mice with WT bone 
marrow. No change in either of these gene transcript levels was detected in mice with leptin 
receptor-deficient bone marrow. The absence of change in this chemokine or its receptor on 
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adipocytes from leptin receptor-deficient bone marrow mice along with the minimal increase in 
TNF-α  suggests that adipose tissue in the leptin receptor chimeric mice has greater insulin 
sensitivity compared to WT counterparts. 
Along with an attenuated inflammatory phenotype in the adipose tissue, chimeric mice 
with leptin receptor deficient bone marrow were resistant to weight and fat mass gain when on a 
HFD. We believe that this effect is not secondary to the lethal total body irradiation intervention. 
A difference in body weight and fat pads weights was measured between HFD and NFD mice 
when they were transplanted with WT bone marrow. This difference that was blunted in the mice 
reconstituted with leptin receptor deficient bone marrow. This would be consistent with previous 
studies that concluded that limiting or preventing inflammation in fat may lead to a decrease in 
weight gain in rodent models of DIO (Davis, Gabler et al. 2008; Chiang, Bazuine et al. 2009). 
Radiation had an impact on the mice used in this study. Total body irradiation by itself 
can affect adipose tissue and prevent weight gain with no effect on food intake or malabsorption 
complications (Ablamunits, Weisberg et al. 2007; Okada, Kobayashi et al. 2007; Poglio, Galvani 
et al. 2009). All the irradiated mice exhibited a stunted growth following the six weeks of 
reconstitution. Nevertheless, mice reconstituted with WT bone were responsive to the HFD and 
gained weight until the end of the sixteen weeks of dietary intervention though the magnitude 
was lower than that observed in the non-irradiated mice. At the end of the study, both 
subcutaneous (inguinal) and intra-abdominal (epididymal) adipose tissue depots also seemed to 
be affected by radiation treatment. Nevertheless, this effect cannot account for the total absence 
of weight gain in the leptin receptor-deficient bone marrow mice, suggesting leptin signaling in 
bone marrow cells to be an independent factor in affecting weight gain as a response to a HFD. 
Studies looking at the effect of radiation on anthropometric parameters in mice showed that in 
the short term (7 days), the lack of weight gain was due to a decrease in both fat cell size and 
number (Poglio, Galvani et al. 2009) while long term studies showed either no difference in 
adipocytes morphology between irradiated and non-irradiated groups (Okada, Kobayashi et al. 
2007) or a decrease in adipocyte hyperplasia but not hypertrophy (Ablamunits, Weisberg et al. 
2007). None of the previous studies examined the combined irradiation and diet-induced obesity 
in mice. The long-term studies used ob/ob mice (Ablamunits, Weisberg et al. 2007; Okada, 
Kobayashi et al. 2007) while short-term studies looked at WT mice (Poglio, Galvani et al. 2009). 
None of the studies included dietary intervention. In our study, irradiated mice on NFD 
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transplanted with either WT or db/db bone marrow gained less fat mass accompanied by 
decreases in adipocyte number and size in the epididymal depot. When switched to a HFD, Irr-
WT and Irr-db mice responded differently. While no significant difference in fat pad weight 
between HFD and NFD was detected in Irr-db mice, HFD led to an increase in adipocyte size 
with a slight decrease in adipocyte number.  In the Irr-WT mice the opposite was observed, as  
HFD increased fat pad weight due to hyperplasia with no effect on adipocyte size.  The lack of 
weight and fat mass gain in Irr-db mice cannot be explained by adipocyte dysfunction because 
TAG uptake and adipogenesis were not compromised. This hypothesis is also supported by 
PPAR-γ gene transcript level in adipocytes, the transcription factor involved in adipogenesis and 
adipocyte differentiation (Barak, Nelson et al. 1999; Rosen, Sarraf et al. 1999). PPAR-γ gene 
transcript level was increased in all irradiated mice irrespective of dietary or bone marrow 
treatment. In addition, the absence of enhanced ectopic fat deposition in the livers of the 
irradiated mice also supports the conclusion of a functional adipose tissue in these mice.  
Our chimeric mice were more insulin sensitive compared to the WT mice based on 
HOMA-IR and insulin measures. This supports the role for the LepRb in the metabolic disorders 
caused by obesity and a HFD which generally lead to tissue specific and general insulin 
resistance. Other studies looking at DIO and insulin resistance used a higher fat concentration in 
their diets (60%) (Weisberg, Hunter et al. 2006; Westcott, Delproposto et al. 2009; Yang, Youm 
et al. 2010) compared to our study (45% calories from fat). Therefore, use of a more aggressive 
dietary approach could potentially lead to a higher difference between the different HFD 
treatment groups. 
In summary, the LepRb contributed to the pathogenesis of obesity and the associated 
inflammatory phenotype in this study. Although the impact was masked by the radiation 
treatment, we have been able to dissect out another component in this complex physiological 
response. Future work may benefit by manipulation of leptin signaling in an adipose tissue 
specific manner as an experimental model and as a possible therapeutic target in efforts for the 




Chapter 3 - Establishment and Characterization of DB-1: A Leptin 
Receptor Deficient Murine Macrophage Cell Line 
  Abstract 
Metabolic and immune mediators activate many of the same signal transduction 
pathways.  Therefore, molecules that regulate metabolism often affect immune responses. Leptin 
is an adipokine that exemplifies this interplay. Leptin is the body’s major nutritional status 
sensor, but it also plays a key role in immune system regulation. We immortalized and 
characterized a leptin receptor-deficient macrophage cell line, DB-1, to provide an in vitro tool to 
investigate the link between leptin and innate immunity. The cell line was created using cells 
from the bone marrow of leptin-receptor deficient (db/db) mice. Bone marrow cells were 
differentiated into macrophages by culturing them with recombinant mouse monocyte colony 
stimulating factor, and passaged when confluent. This treatment was maintained for six months. 
The cells spontaneously immortalized at approximately passage 20.  Cells were cloned twice by 
limiting dilution cloning prior to characterization. The macrophage cell line is diploid and has a 
three-day doubling time. The cells are MAC-2 and F4/80 positive and have phagocytic activity 
similar to primary macrophages from WT and db/db mice. DB-1 cells are responsive to 
stimulation with IFN-γ as measured by increase in Nos2 transcript levels. In addition, DB-1 
macrophages are not responsive to the chemotactic signaling of adipocyte conditioned media nor 
leptin as compared to primary WT macrophages. DB-1 cells provide a dependable tool to study 
the role of leptin or the leptin receptor in obesity-associated inflammation and immune system 
dysregulation. 
 Introduction 
Leptin, the product of the ob gene, is a 16 kDa peptide hormone predominantly secreted 
by white adipocytes (Zhang, Proenca et al. 1994; Ahima and Flier 2000) and is structurally 
similar to type I cytokines (Otero, Lago et al. 2005). Leptin signals through its receptor (LepR) 
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encoded by the db gene (Chen, Charlat et al. 1996).  The LepR exists in six alternatively spliced 
isoforms (Lee, Proenca et al. 1996). The long isoform, LepRb, is a member of the interleukin-6 
receptor family of class 1 cytokine receptors, and is responsible for most of leptin’s 
physiological activities (Tartaglia, Dembski et al. 1995; Baumann, Morella et al. 1996).  
Leptin is involved in a plethora of physiological actions, and plays a major role in the 
regulation of neuroendocrine function and energy homeostasis (Chan, Heist et al. 2003). Leptin 
stimulates the production of anorectic neuropeptides and suppresses the action of orexigenic 
peptides in the arcuate nucleus of the hypothalamus (Cheung, Thornton et al. 1997; Schwartz, 
Seeley et al. 1997; Thornton, Cheung et al. 1997), where LepRb is highly expressed (Elmquist, 
Bjorbaek et al. 1998). This hormone also exerts other physiological effects that impact 
reproduction, hematopoiesis, angiogenesis and immunity (Wauters, Considine et al. 2000). 
Leptin’s effects are exerted through the expression of LepRb on different types of tissues and 
cells throughout the body.  Furthermore, leptin plays an important role in the regulation of both 
innate and adaptive immunity (La Cava and Matarese 2004; Matarese, Moschos et al. 2005), and 
different immune cells express LepRb - which supports the notion that leptin plays a direct role 
in immune function (Matarese, Moschos et al. 2005). T-cells (Batra, Okur et al. 2009), B-cells 
(Papathanassoglou, El-Haschimi et al. 2006), neutrophils (Caldefie-Chezet, Poulin et al. 2003), 
monocytes (Raso, Pacilio et al. 2002), dendritic cells (Mattioli, Straface et al. 2005) and NK cells 
(Tian, Sun et al. 2002) all express LepRb, and leptin modulates their functions in vivo and in 
vitro (Papathanassoglou, El-Haschimi et al. 2006) . 
Leptin induces diapedesis of monocytes and macrophages through an epithelial layer in 
vitro and the production of pro-inflammatory cytokines from both cell types (Curat, Miranville et 
al. 2004; Gruen, Hao et al. 2007).  Leptin augments lipopolysaccharide (LPS)-induced cytokine 
secretion (Gainsford, Willson et al. 1996; Loffreda, Yang et al. 1998) via interleukin-1 receptor-
associated kinase 1 (IRAK-1) up-regulation, (Vaughan and Li 2010) and potentiates IFN-γ-
induced expression of nitric oxide synthase (Raso, Pacilio et al. 2002) in macrophages.  
Non-genetic obesity is characterized by a hyperleptinemic state (Considine, Sinha et al. 
1996) and a compromised immune system (Falagas and Kompoti 2006). Additionally, there is 
increased pro-inflammatory macrophage recruitment in the adipose tissue of obese individuals 
(Weisberg, McCann et al. 2003; Xu, Barnes et al. 2003), and “obese” macrophages have 
impaired phagocytic activity (Krishnan, Trost et al. 1982; Mancuso, Gottschalk et al. 2002). 
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Mechanisms that promote a proinflammatory state in obese animals and people and their 
higher susceptibility to infections remain unclear. This study central hypothesis is that leptin 
contributes directly to this inflammation by regulating macrophage function. The objective here 
was to create a continuous macrophage cell line to allow for investigation of LepRb’s impact on 
macrophage function. The properties of this new leptin receptor-deficient macrophage cell line, 
DB-1 are detailed in this paper. 
 Materials and Methods 
Animals - Male leptin receptor-deficient (db/db) mice as well as gender and aged-
matched wild-type (WT) counterparts were purchased from Jackson Laboratories (Bar Harbor, 
ME). All animal procedures were performed following the Guide for the Care and Use of 
Laboratory Animals with prior approval and regular monitoring of the Institutional Animal Care 
and Use Committee (IACUC) at Kansas State University.   
Reagents - Biomedium was prepared using Dulbecco’s modified Eagle’s medium 
(DMEM, Atlanta Biologicals, Lawerenceville, GA) supplemented with 5% Nu Serum 
(Collaborative Biomedical Products, Bedford, MA), 5% fetal bovine serum (FBS, Atlanta 
Biologicals), 10% Opti-miminum essential media (MEM) reduced serum medium (Invitrogen, 
Carlsbad, CA), 50 μg per ml gentamycin (Sigma-Aldrich, St Louis, MO) and 1.5 ng per ml 
rmM-CSF (R&D Systems, Minneapolis, MN). Cell culture medium was prepared using DMEM 
supplemented with 10% Opti-MEM, 15 mmol/L HEPES and 100  μg p er ml gentamycin. 
Recombinant mouse leptin (rm-Leptin) and IFN-γ were purchased from R&D Systems Inc.  
Fluorescent spheres were purchased from Invitrogen and phorbol 12-myristate 13-acetate (PMA) 
from Sigma. 
Collection of Peritoneal Macrophages - Peritoneal exudate macrophages from WT and 
db/db mice were induced by i.p. injection of 1.5 ml of sterile, 2.9% thioglycollate (DIFCO, 
Detroit, MI). Four days after injection, mice were anesthetized via Isoflurane (IsoFlo, Abbott, 
Abbott Park, IL) inhalation and euthanized via cervical dislocation. Peritoneal exudate 
macrophages were collected by washing the peritoneal cavity twice with 12 ml of ice-cold PBS. 
Differentiation of Bone Marrow Derived Macrophages - Bone marrow cells from db/db 
mice were collected by flushing the humeri, tibiae and femora as described previously 
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(Armstrong, Nelson et al. 1993). The undifferentiated cells were resuspended in Biomedium, 
counted and plated at a density of 3-5×106 cells per 100-mm dish. Cells were incubated at 37°C 
in 8% CO2 and non-adherent cells were removed three days post-seeding by washing the plates 
with PBS and replacing with fresh Biomedium. Adherent cells were dispersed with 
trypsin/EDTA (10% trypsin) to passage the cells. Cells were passed twenty times until 
spontaneous immortalization occurred. For activation and phagocytosis assays, bone marrow 
cells from db/db and WT mice were allowed to differentiate for 7-10 days in Biomedium before 
primary macrophages were used. 
Limiting Dilution Cloning of Cell Lines - Cells were dispersed with trypsin/EDTA and 
resuspended in DMEM supplemented with 10% FBS (DMEM10). Cells were counted and each 
dilution was plated in 48 wells of a Costar 96-well, flat-bottom tissue culture plate. A 1:10 serial 
dilution scheme was used starting at 100 cells/well in 100μl DMEM10 and ending at 0.01 
cell/well. Cells were then incubated at 37°C in 8% CO2. Only clones that grew from dilutions 
having less than a 30% positive growth were selected and expanded. The limiting dilution was 
repeated twice to ensure pure clones. Two final clones were selected and characterization 
experiments were performed using these clones. 
Genotyping of Cell Line - Transcript expression of LepRb gene (NCBI 16847) was 
assessed using qRT-PCR and the following primers: leprb forward 5’- GCA ACC CAC CAT 
GAT TTC ACC ACA-3’; reverse 3’-AGG ATT CCT GCC TCA CCA GTC AAA-5’. The 
internal standard used was β-actin (NCBI number 11461) with the following primers: Actb 
forward, 5’- TGT GAT GGT GGG AAT GGG TCA GAA-3’; Actb reverse, 3’- TGT GGT GCC 
AGA TCT TCT CCA TGT-5’. Fold change in transcript level of each cell type was quantified 
using the method described by Pfaffl (Pfaffl 2001), and the formula employed WT macrophages 
as the reference group:  
Fold change = EΔct target gene (reference-exp)/ EΔct housekeeping gene (reference-exp); 
where E is the efficiency of the primers, and the housekeeping gene is β-actin.  
Cell Cycle Determination - Cell cycle determination and ploidy of the cell line was 
determined using flow cytometry. Briefly, cells were dispersed, collected and counted. Two x 
106 cells were transferred to 12×75-mm polystyrene tubes (Falcon, Brookings, SD). Vindelov’s 
propidium iodide (PI) solution was added and cells were incubated for 5-10 minutes at 4°C 
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(Vindelov, Christensen et al. 1983).  Ploidy was analyzed with singlet discrimination to detect 
PI-stained mononuclear cells. 
Cell Line Proliferation Rate - Cell growth doubling time of the leptin receptor-deficient 
macrophage cell line, DB-1, was determined using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay. Briefly, 1 x105 cells were seeded in 6-well plates. Three 
wells were treated with MTT reagent for 2 hours at each time point. Subsequently, the 
supernatant was removed and IsoPBS (Isopropyl alcohol with 50% PBS and 0.2% 1N HCL) was 
added to dissolve formazan crystals. Color intensity was quantified at 570 nm 
spectrophotometerically (Packard SpectraCount, Packard Instrument Company, Meriden, CT).  
Antibody Phenotyping of Macrophage Cell Lines and Flow Cytometry - DB-1 cells, 
peritoneal macrophages and bone marrow-derived macrophages were probed with antibodies 
raised against the following surface markers: CD11b, F4/80, MAC-2, Ly6G (e-Bioscience, San 
Diego, CA) and Ly6C (BD Pharmigen, San Diego, CA). Appropriate isotype controls were used 
for each antibody as the background labeling for FACS analysis. Briefly, macrophages were 
recovered and plated at 1×105 cells per well of 96-well tissue culture plates. Fc receptors were 
blocked by incubating the cells with 50% goat serum in PBS for 30 minutes at 4°C. Antibodies 
and respective isotype controls were added at the appropriate concentrations and incubated for 1 
hr at 4°C. Cells were washed twice with Hank’s buffered salt solution (HBSS). Cells were 
transferred to 12×75-mm polystyrene tubes, washed once with HBSS and resuspended in 200 μl 
of 1% formalin/HBSS. The cells were placed on ice and the amount of labeling of each marker 
was assessed by flow cytometry using a FACS Caliber analytical flow cytometer (Becton 
Dickson, San Jose, CA) measuring 5,000 events per sample. Data analysis was performed with 
WinList software (Verity Software House, Topsham, ME). The amount of labeling of each 
marker was assessed after subtracting the percent positively labeled cells in the isotype control 
groups. 
Phagocytosis Assays - Bone marrow-derived, peritoneal and DB-1 macrophages were 
dispersed with trypsin/EDTA, recovered, and 1×106 cells were seeded per well in 24-well tissue 
culture plates. Cells were incubated at 37°C in 8% CO2 for 2 hours. Cytochalasin D from 
Zygosporium mansonii (Sigma Aldrich) was added at a final concentration of 10 µM to control 
plates to inhibit phagocytosis. These plates were incubated at 4°C for 2 hrs to further inhibit 
phagocytosis. Experimental plates were kept at 37°C. Red fluorescent beads (diameter, 0.2 μm; 
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Invitrogen) were added to each well to a final concentration of 0.1%. Phagocytosis was stopped 
after 60 min by centrifuging the 24-well plates at 350×g for 5 min, removing the supernatant, and 
washing twice with PBS. The cells were transferred to 12×75-mm polystyrene tubes, washed 
twice with PBS and resuspended in 200 μl of 1% formalin/PBS. The cells were placed on ice and 
phagocytosis was assessed by flow cytometry and measuring 10,000 events per sample. The 
percentage of phagocytic cells in each experimental group was assessed after subtracting the 
percentage phagocytic cells of the control plates. 
Activation of DB-1 with rm-IFNγ - DB-1 cells were stimulated with IFN-γ, to determine 
whether DB-1 macrophages respond to this stimuli in the same fashion as primary macrophages 
and expression of nos2 was assessed. Briefly, primary WT, db/db and DB-1 macrophages were 
plated separately in 24-well plates at a density of 1 x 106 cells per well and incubated with or 
without IFN-γ (100 U/ml, R&D Systems, Minneapolis, MN) for 16 hours. RNA was collected 
using TRI reagent (MRC, Cincinnati, OH) and further purified with DNAse using the E.Z.N.A 
Total RNA kit (Omega Bio-Tek, Norcross, GA). Gene expression of nos2 (NCBI number 18126) 
was quantified using qRT-PCR with the following primers: nos2 forward, 5’- CTG CTG GTG 
GTG ACA AGC ACA TTT-3’; nos2 reverse, 3’- ATG TCA TGA GCA AAG GCG CAG AAC-
5’. β-actin was quantified using the previously mentioned primers. Fold change in transcript 
level of each cell type was quantified using the Pfaffl method as described above.  
Adipocyte Collection and Conditioned-Medium Preparation - Adipocytes from 
epididymal and inguinal fat pads of obese and lean male C57BL/6 mice were collected in cell 
culture medium, pooled and minced into small pieces. Tissue was digested in Krebs Ringer 
Buffer (KRB) containing 1 mg/ml type II collagenase (Sigma-Aldrich) in a shaking incubator for 
40 min at 37°C. The digested tissue was filtered through nylon cell strainers (100 µm; Fisher 
Scientific, Pittsburg, PA), washed with KRB, and separated by centrifugation for 1 min at 350 x 
g. The floating adipocytes were collected and cultured in DMEM at 37°C, 8% CO2 for 24 hrs. 
The adipocyte-conditioned medium (ACM) containing all factors released by the adipocytes was 
collected and used for migration experiments with thioglycollate elicited peritoneal and DB-1 
macrophages. Control medium (CM) was obtained using the same protocol but without adding 
adipocytes. Media were stored at -80°C until use. 
Migration Assay - Wild-type peritoneal macrophages were collected as described above 
and suspended in serum-free culture medium. Cells were placed in the upper chamber of a 
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polystyrene filter (5 μm pore size, 6-transwell format; Corning, Lowell, MA). Cells were allowed 
to adhere for 3 hours, at which point medium in the lower chamber was replaced with CM 
(negative control), ACM, CM supplemented with 10ng/ml rm-leptin, or CM supplemented with 
2 µM PMA. After 3 hrs, cells that had not migrated and remained in the upper chamber were 
removed by gently swiping the filters with cotton tips. Filters were fixed in 2% ethanol for 5 
minutes. Cells located on the lower side of the filter were stained with Diff-Quick (Dade 
Diagnostics, Aguada, PR), and counted as migrated cells. These cells were quantified from 5-10 
fields/condition and cell type. 
Statistical Analysis - Results are reported as mean ± standard deviation (std) unless 
otherwise specified. ANOVA was performed and least significant differences (LSD) were 
calculated when appropriate. Analysis was conducted using SPSS software (version 17.0, SPSS 
Inc. Chicago, IL). Statistical significance was determined at p-value <0.05. 
 Results 
 Establishment of DB-1 cell line  
An immortal leptin receptor-deficient cell line from mouse bone marrow-derived 
macrophages was established.  Bone marrow cells from db/db mice were collected and cultured 
in Biomedium as described in the Materials and Methods section. Differentiated macrophages 
were passaged at confluency. Cells were kept in Biomedium for 6 months when the cells 
appeared to grow at a stable rate after twenty passages. At that time, we did two consecutive 
limiting dilution clonings. The DB-1 cells were expanded from one clone selected from the 
second cloning procedure. DB-1 cells lost their dependency to M-CSF after the cloning process. 
They were re-expanded and shifted to a regular medium, DMEM supplemented with 2% Nu 
serum and 2% FBS.  DB-1 cells exhibit morphological properties characteristic to macrophages, 
and are adherent with multiple processes (Figure 3.1).   
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Figure 3.1 Morphological aspects of DB-1 cells using light photo micrographs. A, B in culture flask at 
magnification 10x and 20x, respectively.  
 
Quantification of gene transcript levels of LepRb was performed to confirm the leptin-
receptor deficient genotype of DB-1 cells using qRT-PCR.  Similarly to primary peritoneal db/db 
macrophages, DB-1 had low levels of LepRb transcripts, and expression ranged from 0.1 to 12 % 
of WT macrophages (p<0.05, Table 3.1). 
 
Table 3.1 Relative gene expression of LepRb in DB-1 and peritoneal db/db macrophages compared to 
WT peritoneal macrophages. 
Cell type Percentage fold expression compared to WT macrophages§ 
db/db macrophages# 1.4 (0.1-3.5)* 
DB-1 macrophages 1.05 (0.1-12)* 
#Results from 4-6 samples per group, are reported as median (range).  
§Fold expression was calculated according to Pfaffl method (Pfaffl 2001) using WT values as control group 
and β-actin as the reference gene. 
*p<0.05 compared to 100% expression in WT macrophages 
 
 
Cell cycle analysis was conducted using flow cytometry (Vindelov, Christensen et al. 
1983) to assess DB-1 ploidy and cell cycle distribution. The DB-1 cell line was homogenous 
consisting of 100% diploid cells, of which 90-95% cells were in G1 phase, 3 to 9% in G2 phase 
and 0 to 2% in S phase.  




DB-1 cell growth was analyzed via a MTT assay, and cell doubling time was estimated to 
be approximately 3 days (Figure 3.2).  
 
          
Figure 3.2 DB-1 cells exhibit a 3 day doubling time.  
Cell growth was assayed at different days after seeding of 1x105 DB-1 cells in 6-well plates using MTT. Each time 
point value is the mean of triplicate readings. OD= Optical density. 
 
 
Cell growth plateaued at day 10 and the cells remained stable until day 22 when the 
experiment was terminated.  The slow growth rate along with the growth arrest at confluency is 
consistent with a cell line that is non-transformed and contact inhibited (Schuler, Jefferson et al. 
1977).  
Cell Surface Phenotype  
Cell surface antigens of DB-1 cells were compared to those of primary peritoneal and 
bone marrow-derived macrophages to verify that DB-1 cells belong to the monocyte/macrophage 
lineage. Primary macrophages expressed similar levels of F4/80 and MAC-2, regardless of their 
expression of LepRb (Figure 3.3). Bone marrow-derived macrophages exhibited less expression 
of CD11b and higher expression of Ly6C compared to the peritoneal macrophages. All cell 
types, including the DB-1 cells displayed minimal expression of Ly6G, the granulocyte marker, 
on their surface.  DB-1 cells displayed MAC-2 in similar amounts as both bone marrow-derived 
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and peritoneal WT and db/db macrophages. In contrast, F4/80 was minimally expressed and 
CD11b was not expressed at all in DB-1 macrophages. Ly6C was expressed by DB-1 cells at an 
intermediate level between that of the bone marrow-derived and peritoneal macrophages (Figure 
3.3). These data suggest that the DB-1 cells are intermediately matured in the macrophage 
lineage (Leenen, Melis et al. 1990) with high MAC2 expression, lower expression of F4/80 and 
low levels of Ly6C.  
                
Figure 3.3 DB-1 cells exhibit macrophage lineage cell surface markers. 
CD11b, MAC-2, F4/80, Ly-6C and Ly6G cell surface expression in peritoneal (PEC WT) macrophages,  peritoneal 
(PEC db/db) macrophages, primary WT bone marrow (BM WT), primary db/db bone marrow (BM db/db) and DB-1 
macrophages (DB) using flow cytometry. Data represent means ± std, from two independent experiments, n=2-5 
replicates per experiment, each n from one or a pool of 2 mice.   
 
 Phagocytic Activity  
Phagocytic activity of DB-1 cells was measured and compared to that of primary 
macrophages in order to assess whether DB-1 cells display functional macrophage characteristic. 
We concluded that all five cell-types - including the DB-1 cells – exhibited no statistical 





                 
Figure 3.4 DB-1 cells exhibit the same phagocytic activity as peritoneal (PEC) and bone-marrow (BM) derived WT 
and db/db macrophages. 
Cells were incubated with fluorescent beads and phagocitic activity assessed via the percentage of phagocytosed 
beads using flow cytometry. Data represent means ± std, from one or two independent experiments, n=3-6 replicates 
per experiment, each n from one or a pool of 2 mice.   
 
DB-1 Respond to IFN-γ Stimulation 
DB-1 macrophages were exposed to IFN-γ and transcript levels of Nos2 were quantified 
to determine if DB-1 cells respond to a stimulus in a similar fashion as primary macrophages. 
Nos2 transcript levels were higher after IFN-γ treatment with levels similar to peritoneal db/db 
macrophages (p<0.05, Table 3.2). 
 
Table 3.2 Relative gene expression of nos2 in DB-1 and peritoneal db/db macrophages after stimulation with 
IFN-γ compared to non-stimulated cells. 
Cell type Percentage fold up-regulation compared to no treatment group$ 
db/db macrophages# 1.4 (0.1-3.5)* 
DB-1 macrophages 1.1 (0.1-12)* 
*Results from 5-8 samples per group, are reported as median (range). $Fold expression was calculated 
according to Pfaffl method (Pfaffl 2001) using no treatment values as control group and β-actin as the 





 Migration Assay  
Migration assays were performed using both peritoneal WT and DB-1 cells to quantify 
the response of these cells to the chemotactic effect of adipocyte conditioned medium or leptin. 
DB-1 macrophages migrated when activated with PMA (p<0.05), but that they failed to respond 
to the chemotactic signals from the ACM as well as the medium supplemented with leptin 
(Figure 3.5). On the other hand, primary WT macrophages exhibited a significant increase in 
migration when cultured with either the ACM or leptin (p<0.01; comparison to medium alone) 
with no statistically significant difference between the two media (p>0.05; Figure 3.5); 
suggesting that most of the ACM chemotactic potential is mediated by leptin, and dependent on 
the presence of a functional LepRb. 
 
       
Figure 3.5 DB-1 cells fail to migrate following stimulation with adipocyte-conditionned media or leptin. 
 Migration assay was carried using a transwell system. The lower chamber was supplemented with control medium 
(CM), adipocyte conditionned medium (ACM), CM supplemented with 10ng/ml rm-leptin or CM supplemented 
with 2 µM phorbol 12-myristate 13-acetate (PMA). Values are means ± std. Data of 1 experiment with n=3 





A leptin-receptor deficient cell line, DB-1, was derived from murine bone marrow. This 
cell line has phenotypic and functional properties characteristic of macrophages.  It is diploid, 
lacks the long isoform of the leptin receptor, and is unresponsive to leptin. 
 Characteristics of DB-1 cells are comparable to ex vivo bone marrow-derived and 
thioglycollate-elicited peritoneal WT and primary leptin receptor-deficient macrophages. We 
show that DB-1 cells exhibit higher levels of MAC-2 expression and lower levels of Ly6C, 
indicating that these cells belong to the macrophage lineage and have immortalized at a 
intermediate-to-late stage of macrophage differentiation (Leenen, de Bruijn et al. 1994). The DB-
1 Ly6C expression is intermediate between that of peritoneal macrophages and seven-day, M-
CSF-differentiated bone marrow-derived macrophages. The difference in primary Ly6C 
expression in bone marrow compared to peritoneal macrophages suggests that 7-day in vitro 
differentiation is not enough to yield fully mature macrophages (Chan, Leenen et al. 1998).  The 
DB-1 macrophages are responsive to IFN-γ, which supports the conclusion that these cells are 
mature macrophages; given that NOS2 production is a property of mature macrophages 
(MacMicking, Xie et al. 1997).  
DB-1 cells are phagocytic in vitro. The strong phagocytic activity of the DB-1 cells 
supports the notion that these cells are in the macrophage lineage (Leenen, Jansen et al. 1986). In 
this study, the LepRb did not contribute to macrophage phagocytosis. The lack of the leptin gene 
(ob/ob) as well as the leptin receptor gene (db/db) have been associated with an enhanced 
susceptibility to infections and a higher mortality rate in rodents following bacterial infection 
(Mancuso, Gottschalk et al. 2002; Ikejima, Sasaki et al. 2005; Ordway, Henao-Tamayo et al. 
2008; Park, Rich et al. 2009). This increased risk of infection has been attributed to a decrease in  
phagocytic and bactericidal activity of ob/ob and db/db macrophages in vitro (Loffreda, Yang et 
al. 1998; Mancuso, Gottschalk et al. 2002; Park, Rich et al. 2009). The difference in phagocytic 
activity between DB-1 cells and that of ob/ob and db/db primary macrophages evaluated in other 
studies might be explained by the fact that inert fluorescent beads were used in this study 
compared to actual infectious agents (Loffreda, Yang et al. 1998; Mancuso, Gottschalk et al. 
2002; Park, Rich et al. 2009). However, DB-1 macrophages’s ability to phagocytose fluorescent 
Ehrlichia chaffeensis bacteria was comparable to that of primary macrophages (data not shown). 
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Therefore, the difference between our study and data presented by others may be due to other 
physiological factors such as a compromised oxidative response (Hsu, Aronoff et al. 2007) in 
immune cells or inefficient leukotriene production (Mancuso, Gottschalk et al. 2002); products 
that were compromised in primary db/db and ob/ob macrophages.  It is also possible that 
physiological factors associated with diabetes such as hyperglycemia may have an impact.  Parks 
and collegues showed similar infection rates in mice between 8-11 week-old db/db mice and WT 
controls but older (20 weeks and more) db/db mice were significantly more susceptible to S. 
aureus infection (Park, Rich et al. 2009).  The cell line would not be subject to the physiological 
regulation of the in vivo macrophages.     
Obesity is associated with an increase in inflammatory macrophage recruitment to the 
expanding fat mass (Weisberg, McCann et al. 2003; Xu, Barnes et al. 2003). Studies have 
recognized MCP-1 as the major adipocyte-derived chemokine responsible for this effect (Kanda, 
Tateya et al. 2006; Weisberg, Hunter et al. 2006). Nevertheless, recent studies have questioned 
this chemokine’s role in the enhanced recruitment of macrophages into the adipose tissue of 
obese mice (Inouye, Shi et al. 2007). Leptin is another candidate adipokine/chemokine that might 
be responsible for this recruitment effect. Indeed, our data show that adipocyte-conditioned 
media as well as leptin-supplemented media have the same positive chemotactic effect on WT 
macrophages. DB-1 cell line, which lacks the functional LepRb, failed to respond to both leptin-
supplemented and adipocyte-conditioned media, although this cell line responded better than the 
WT macrophages to PMA.  Therefore, LepRb has a physiological function and DB-1 cells are 
refractory to leptin and supports the studies of  Gruen et al, who  have shown leptin‘s 
chemotactic effects at levels as low as 1 pg/ml (Gruen, Hao et al. 2007).  
The body’s nutritional status, ranging from starvation or obesity, affects immune function 
(Dixit 2008). In an era characterized by increasing obesity rates (Ogden, Carroll et al. 2006), it is 
of central importance that the immunological consequences of excessive body weight be further 
elucidated. The newly established DB-1 cell line can serve as an important and reliable tool to 
study the link between leptin and innate immune function.  
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Chapter 4 - Role of Leptin in Obesity-Associated Infection 
Susceptibility 
 Abstract 
Obesity is associated with an increased risk of infection and compromised immune 
responses. Leptin plays a role in both innate and adaptive immunity and its plasma concentration 
changes in response to infection, therefore we hypothesized that obesity would affect the host 
response to an experimental infection by Ehrlichia chaffeensis. We experimentally challenged 
three groups of male C57Bl/6J mice, obese, lean and young lean with E. chaffeensis. Serum 
leptin, IL-6 and TNF-α were measured at 0, 3, 6 & 9 days post-infection and  bacterial infection 
was assessed 6 and 9 days post-infection using qRT-PCR. Obese mice experienced the most 
weight loss after infection. All groups had a similar increase in inflammatory cytokines and 
leptin was decreased similarly in all groups. Although, no differences were measured between 
lean and obese mice in the kinetics of bacterial clearance, we did see some differences in some 
individual immune functions.  “Obese” peritoneal macrophages were significantly less 
phagocytic than macrophages from lean mice. Supplementation with 500 ng/ml rm-leptin 
significantly increased the obese macrophages' phagocytic activity but had no effect on lean 
macrophages. Leptin treatment did not affect phagocytosis by macrophages from uninfected 
mice.  
 Introduction 
Epidemiological and observational studies have established a strong link between obesity 
and the development of several types of infections. Obese people have a higher risk of 
developing nosocomial, surgical site, odontogenic, respiratory, urogenital, skin, bone and liver 
infections compared to leaner counterparts (Falagas and Kompoti 2006; Serrano, Khuder et al. 
2010). In the March 2010 report, the Centre for Disease Control (CDC) declared obesity to be an 
independent risk factor for hospitalization and death due to the 2009 H1N1 epidemics 
(http://www.cdc.gov/h1n1flu/in_the_news/obesity_qa.htm) in Canada, New Zealand, Australia 
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and the U.S.A. (Miller, Markewitz et al. ; Kumar, Zarychanski et al. 2009; Louie, Acosta et al. 
2009; Webb and Seppelt 2009). 
Infection is also affected by obesity in rodents. Genetic and diet-induced obese (DIO) 
mice exhibit a blunted immune response and a delayed pathogen clearance when infected with 
either bacterial or viral agents (Mancuso, Gottschalk et al. 2002; Amar, Zhou et al. 2007; Smith, 
Sheridan et al. 2007). Additionally, infected DIO mice have a higher mortality rate compared to 
lean controls secondary to influenza viral infections (Smith, Sheridan et al. 2007; Karlsson, 
Sheridan et al. 2010 
). Macrophages isolated from either obese humans or mice have an impaired phagocytic 
and bactericidal activity ex-vivo (Krishnan, Trost et al. 1982; Mancuso, Gottschalk et al. 2002). 
These “obese” macrophages exhibit a blunted cytokine response (Amar, Zhou et al. 2007), a 
defective oxidative response and increased levels of carboxyl-terminal modulator protein 
(CMTP), an inhibitor of Akt phosphorylation in macrophages (Zhou, Leeman et al. 2009; Zhou, 
Leeman et al. 2011). Therefore, there are many factors that contribute to the defective activation 
of “obese” macrophages after bacterial challenge. 
Leptin is a small peptide mainly secreted by adipocytes in proportion to adipose tissue 
mass and the degree of obesity (Considine, Sinha et al. 1996). This hormone is a pleiotropic 
adipocytokine involved in energy homeostasis, reproduction, hematopoeisis and innate and 
adaptive immunity (Matarese, Moschos et al. 2005). Leptin induces a TH1 pro-inflammatory 
response, activates NK cells, stimulates macrophage cytokine secretion and is a potent 
chemokine for neutrophils and monocytes (La Cava and Matarese 2004). Genetically obese mice 
lacking either leptin (ob/ob) or its receptor (db/db) are more prone to opportunistic infections and 
are resistant to autoimmune diseases (Sanna, Di Giacomo et al. 2003; Ikejima, Sasaki et al. 
2005), thus highlighting the role of leptin in generating normal immune responses. Restoring 
leptin concentrations to normal in either ob/ob or starved mice (low leptin levels) lead to a 
normalization of immune responses and a restoration of normal bacterial clearance (Mancuso, 
Gottschalk et al. 2002; Sanna, Di Giacomo et al. 2003; Mancuso, Huffnagle et al. 2006). The 
same has been observed in vitro where supplementation of ob/ob macrophages with leptin 
restored macrophage phagocytic activity (Mancuso, Gottschalk et al. 2002).   
In obesity, leptin signaling and regulation is impaired, leading to leptin resistance in 
central and possibly peripheral tissues (Klein, Horowitz et al. 2000; Schwartz, Woods et al. 
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2000). Karlsson et al. (2010) and Smith et al. (2007) reported that, contrary to the acute and 
sharp increase in leptin levels seen in lean mice post-infection; DIO mice have an acute systemic 
decrease in leptin levels after influenza infection. Since leptin is involved in the activation of 
innate and adaptive immunity, the decrease in DIO mice might explain their ineffective viral 
clearance, though this link was not established conclusively (Smith, Sheridan et al. 2007; 
Karlsson, Sheridan et al. 2010). Therefore, there is a need to show a direct cause and effect 
between obesity and infection and establish the mechanisms involved.  
Ehrlichia chaffeensis is an obligate, macrophage/monocyte-tropic intracellular bacterium. 
In humans, it causes monocytic ehrlichiosis, which can be lethal in the young, elderly, and/or 
immunocompromised subjects (McNabb, Jajosky et al. 2008). E. chaffeensis is classified as a 
Gram-negative bacterium, but it lacks the genes necessary for the synthesis of peptidoglycan or 
lipopolysaccharide (LPS) (Lin and Rikihisa 2003). Though E. chaffeensis is taken up by 
macrophages, these cells fail to clear the infection by themselves allowing the bacteria infection 
to persist through yet undefined evasion mechanisms (Ganta, Cheng et al. 2004). Nevertheless, 
immunocompetent mice clear E. chaffeensis infection by 10-14 days through a process requiring 
both innate and adaptive immunity players and involving macrophage activation, major 
histocompatibility complex class II (MHCII) molecules, and CD4+ helper T-cell responses 
(Ganta, Cheng et al. 2007). 
We hypothesized that the leptin response to E. chaffeensis infection would be impaired in 
obese mice and would compromise the immune response.  E. chaffeensis was a good choice of 
challenge agent because it was opportunistic and prolonged infections would reveal changes to 
the host defense system. 
 Materials and Methods 
Animals- Male leptin receptor-deficient (db/db) mice and gender and aged-matched wild-
type (WT) counterparts were purchased from Jackson Laboratories (Bar Harbor, ME). After 1 
week adaptation, mice were randomized to receive either the high fat diet (HFD, D12492, 45 
kcal% from fat, Research Diets Inc., New Brunswick, NJ) (the obese group OB) or the normal 
fat diet (NFD, D12450B, 10% kcal from fat, Research Diets Inc., New Brunswick, NJ) (the lean 
group LE) for sixteen weeks. At the end of the sixteen weeks, another mouse group, 6-weeks old, 
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was added (young group YO) and all mice were infected as described below.  All animal 
procedures were performed following the Guide for the Care and Use of Laboratory Animals 
with the prior approval and regular monitoring of the Institutional Animal Care and Use 
Committee (IACUC) at Kansas State University.   
E. chaffeensis Quantification and Mouse Infections- E. chaffeensis was grown in canine 
DH82 cells as described previously (Luce-Fedrow, Von Ohlen et al. 2009).  Cultured bacteria 
from 100 mm culture plates were harvested when 80 to 100% of the confluent DH82 cells were 
infected. The cell suspension was diluted 1:1 in phosphate-buffered saline (PBS), and 0.5 ml of 
the suspension (∼5 × 106 cells) was injected intraperitoneally (i.p.) per mouse as described 
previously (Ganta, Wilkerson et al. 2002). Aliquot of the injection suspension were sampled to 
assess the number of E. chaffeensis bacteria per inocula using qRT-PCR with established primers 
(Ganta, Wilkerson et al. 2002). Cycle threshold (CT) values were plotted on standard curves 
generated by plotting the log number of bacteria versus the corresponding threshold cycle value 
and number of bacteria per inocula was calculated as described by our group (Luce-Fedrow, Von 
Ohlen et al. 2009).  Infected mice were sacrificed and evaluated 6 and 9 days post-infection.  
RNA Isolation and E. chaffeensis rRNA Gene-Specific qRT-PCR- RNA from peritoneal 
exudate cells, spleen, lungs and epididymal fat tissue samples was extracted 6 and 9days  post-
infection, using the TRI reagent/chloroform method according to manufacturer’s procedure. 
RNA was purified and DNAse treated using E.Z.N.A Total RNA kit and RNase Free DNase Set 
(Omega Bio-Tek, Norcross, GA). Quality of the extracted RNA samples was analyzed using the 
Agilent Bioanalyser (Agilent Technologies, Bracknell, UK).  qRT-PCR was performed using a 
TaqMan-based real-time RT-PCR as previously described (Sirigireddy and Ganta 2005). The 
internal control gene used was β-actin (NCBI number 11461) with the following primers: Actb 
forward, 5’- TGT GAT GGT GGG AAT GGG TCA GAA-3’; Actb reverse, 3’- TGT GGT GCC 
AGA TCT TCT CCA TGT-5’. Fold change in transcript level for each tissue and mouse group 
was quantified using the method described by Pfaffl below formula (Pfaffl 2001), and using 
young (YO) group as the reference group:  
Fold change = EΔct target gene (reference-exp)/ EΔct housekeeping gene (reference-exp); 
where E is the efficiency of the primers, and the housekeeping gene is β-actin.  
Serum Cytokine/Adipokine Analysis- Mice were anesthetized systemically using 
isoflurane and locally with proparacaine hydrochloride and blood was collected from the retro-
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orbital sinus at 0, 3, 6 and 9 days post-infection. Serum was separated and frozen at -80°C until 
analysis. Serum leptin and IL-6 were measured by fluorescent immunoassay using a Milliplex 
MAP kit for mouse serum adipokine (Millipore, St. Charles, MO) according to the 
manufacturer’s instructions. The samples were processed on a Luminex 100, and results were 
analyzed with MasterPlexQT software (MiraiBio, South San Francisco, CA, USA). 
Fluorescent Labeling of Bacteria for Injection- E. chaffeensis was purified as described 
above and was labeled with fluorescein as previously described (Luce-Fedrow, Von Ohlen et al. 
2009). Briefly, fluorescein isothiocyanate (FITC) was dissolved into 0.2 M Na2CO3 (pH 9.5) 
buffer to a final concentration of 5 mg per ml. One milliliter of the FITC solution was added to 
the cell-free E. chaffeensis pellet, mixed gently, and incubated with rocking for 15 min at room 
temperature (protected from light). The FITC-bacterium mixture was then added to 4 ml of 135 
mM NaCl-10 mM phosphate buffer (pH 7.4) and incubated for 5 min at room temperature. The 
mixture was then centrifuged at 10,000 x g for 5 min and the pellet was resuspended in 2.83% 
Na2HPO4 (pH 8.5), and the mixture was centrifuged again. The resulting pellet was resuspended 
in sterile PBS and subsequently washed three times with sterile PBS. The bacterial pellet was 
resuspended in sterile PBS for the phagocytic assay and an aliquot was taken to measure bacterial 
number as described above. 
Collection of Peritoneal Macrophages - Peritoneal macrophages were collected from 
infected OB, LE and YO mice at day 9 post-infection by washing of the peritoneal cavity twice 
with 12 ml of ice-cold PBS. Peritoneal exudate macrophages from non-infected OB, LE and YO 
mice were induced by i.p. injection of 1.5 ml of sterile, 2.9% thioglycollate (DIFCO, Detroit, 
MI). Four days after injection, mice were anesthetized with Isoflurane (IsoFlo, Abbott, Abbott 
Park, IL) inhalation and euthanized via cervical dislocation.  
Phagocytosis Assays - Peritoneal macrophages were collected from infected and non-
infected OB, LE and YO groups as described above. One × 106 cells were seeded per well in 24-
well tissue culture plates. Cells were supplemented with or without recombinant mouse leptin 
(rm-leptin, Sigma-Aldrich, St. Louis, MO) at concentrations of 500 or 5000 ng/ml and were 
incubated at 37°C in 8% CO2 overnight. Cytochalasin D from Zygosporium mansonii (Sigma 
Aldrich) was added at a concentration of 10 µM to control plates to inhibit phagocytosis 
(Mordica, Woods et al. 2009). These plates were incubated at 4°C for 2 hrs to further inhibit 
phagocytosis. Experimental plates were kept at 37°C. One hundred µl of fluorescein-labeled 
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bacteria were added to each well.  Phagocytosis was stopped after 60 min by centrifuging the 24-
well plates at 350×g for 5 min, removing the supernatant, and washing twice with PBS. The cells 
were transferred to 12×75-mm polystyrene tubes (Falcon, Brookings, SD), washed twice with 
PBS and resuspended in 200 μl of 1% formalin/PBS. The cells were placed on ice and 
phagocytosis was assessed by flow cytometry (FACS Caliber, Becton Dickson, San Jose, CA) 
measuring 10,000 events per sample. The percentage of phagocytosis in the experimental groups 
was assessed after subtracting the percentage phagocytosis of the negative control treatment 
group. 
 Statistical Analysis - Results are reported as mean ± standard deviation (std) unless 
otherwise specified. ANOVA was performed and least significant differences (LSD) were done 
when appropriate. Analysis was conducted using SPSS software for Windows version 17.0 
(SPSS Inc. Chicago, IL). Statistical significance was determined at p-value <0.05. 
 Results 
Animal Model of Infection  
Mice in the obese group (OB) and age-matched lean group (LE) were 24 weeks old and 
had an average weight of 40.9 ± 7.1 g and 30.2 ± 2.6g respectively (p<0.05, Table 4.1). Young 
mice (YO) were 6 week old with an average weight of 20.3 ± 0.7g, statistically different from the 
other two groups (p<0.05, Table 4.1). Young mice were used as a comparison for the age effects 
that might be induced by the 16-week diet protocol. 
Obese Mice had the Highest Percentage Weight Loss Secondary to Infection  
Weight loss is often used as a measure of pathogen stress (Iandolo and Chapes). 
Therefore, percentage weight loss was calculated at different time points post-infection as a 
measure of morbidity due E. chaffeensis infection.  Both the obese (OB) and the age-matched 
lean (LE) groups lost weight at day 3 compared to baseline (4 and 3% respectively) with only the 
OB having a significant weight loss (p<0.05). Unlike LE mice, OB mice failed to recover lost 
weight by study termination. In fact, at day 6, average weight loss in the OB group was still 
depressed 4% compared to their baseline weight while LE mice had completely regained the lost 
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weight. Lean young mice (YO) did not lose any weight, in fact at study termination they gained 
an average of 8% compared to their baseline weight (p<0.05, Figure 4.1). 
  
Figure 4.1 Infection stress after infection with E. chaffeensis.  
Weight loss as a percentage of initial weight was calculated  at 3, 6 and 9 days post infection in obese (OB), age-
matched lean (LE) and young lean (LE) mice. * p<0.05 compared to zero. a,b values with different letters are 
statistically different between groups at different time points at p<0.05. 
 
 All Mice had an increase in inflammatory cytokines till study termination  
Circulating inflammatory cytokines, TNF-α and IL-6 were measured during the course of 
the infection to assess the magnitude of systemic inflammation after experimental challenge. All 
mouse groups had a significant increase in both cytokines at day 9 compared to baseline values 
(Table 4.1). No difference was detected in overall fold change from baseline between all groups 
for IL-6 (1.5 ± 0.5, 13.5 ± 15.2 and 3.7 ± 1.3 in YO, LE and OB groups respectively, p>0.05 
Table 4.1) and TNF-α (5.1 ± 1.2, 13.9 ± 7.1 and 14.1 ± 5.7 in YO, LE and OB groups 
respectively, p>0.05, Table 4.1).  As expected, leptin levels were highest in the obese group 
compared to both LE and YO groups at all times (p<0.01, Table 4.1). All groups experienced a 
significant decrease in absolute leptin levels at day 9 compared to baseline values (Table 4.1) but 
the fold change from baseline was not different between groups (0.6 ± 0.4, 0.5 ±0.2, 0.5 ± 0.3, in 
YO, LE and OB mice respectively, p>0.05, Table 4.1). This decrease cannot be explained by 
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weight loss since LE regained their lost weight and YO mice actually gained weight by the end 
of the study. 
 
Table 4.1 Serum levels of leptin, IL-6 and TNF-α at days 0, 3, 6 and 9 post E. chaffeensis infection in obese (OB), 



























* p-value from ANOVA analysis between groups. #Different from value at time zero within the same group, 
p>0.05. NS not significant 
  Tissue Bacterial Load was not Different between Obese and Age-Matched Lean 
Controls 
To test whether obese mice had impaired resistance to E. chaffeensis infection, we 
examined bacterial load in spleen, liver, epididymal fat and in peritoneal exudate cells by qRT-
PCR looked at different organs and quantified the amount of bacteria by qRT-PCR. There was 
no difference in percentage fold change in bacteria transcript levels between OB and LE groups 
when compared to the YO group (p>0.05, Table 4.2) or when compared to each other (data not 
showed). In WAT, PEC and lungs, there was a lower percentage of bacteria transcript levels in 
both LE and OB compared to YO (Table 4.2). Nevertheless, we believe that none of the groups 
totally cleared the infection. 
 Day Young (YO) Lean (LE) Obese (OB) p-Value* 
Leptin, ng/ml 0 3 ± 0.6 8.2 ± 2.7 28 ±4.8 0.0001 
 3 2 ± 0.3 5.6 ± 1.6 21.2 ±4.6 0.0001 
 6 1 ± 0.2 4.7 ± 1.1 15.8 ± 2.9 0.0001 
 9 1.5 ± 0.2# 4.6 ± 1.6# 9.5 ± 3.3# 0.01 
Fold change from baseline$ 0.6 ± 0.4 0.5 ± 0.2 0.5 ± 0.3 NS 
IL-6, pg/ml 0 6.8 ± 1.7 5.6 ± 0.7 6.1 ± 0.8 NS 
 3 9.4 ± 3.3 10.9 ± 1.5 14.3 ± 1.8 NS 
 6 9.3 ± 1.3 13.8 ± 0.9 15.5 ± 2.2 0.04 
 9 10.9 ± 4 24.6 ± 3.8# 19 ± 1.0# NS 
Fold change from baseline       1.5 ± 0.5 13.5 ± 15.2 3.7 ± 1.3 NS 
TNF-α, pg/ml 0 1.8 ± 0.3 2.6 ± 0.9 1.4 ± 0.2 NS 
 3 3 ± 0.5 3 ± 0.7 4.3 ± 1.2 NS 
 6 7.9 ± 1.2 13.2 ± 1.1 8.9 ± 0.9 0.004 
 9 8 ± 1# 19.4 ± 0.7# 15.5 ± 2.8# 0.004 
Fold change from baseline 5.1 ± 1.2 13.9 ± 7.1 14.1 ± 5.7 NS 
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Table 4.2 Percentage fold change in mRNA transcript levels in lean (LE) and obese (OB) mice with the young (YO) as the reference group using the Pfaffl 
(Pfaffl 2001) method for calculations. Data are presented as Median (range). 
 
  
Spleen Lungs WAT PEC 
 
Day 6 Day 9 Day 6 Day 9 Day 6 Day 9 Day 6 Day 9 
Lean (LE) 97 (41-132) 58 (10-227) 53 (33-192) 15 (8-74)* 29 (6-75)* 29 (10-370) 83 (70-121) 34 (9-64)* 
Obese (OB) 100 (23-164) 145 (28-251) 75 (38-174) 15 (7-64)* 27 (13-268) 10 (4-11)** 51 (20-92)* 17 (6-62)** 
*Significantly different from 100% as per one sample t-test, p<0.05 
** Significantly different from 100% as per one sample t-test, p<0.01 
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 Macrophages isolated from infected obese mice have a compromised phagocytic 
activity in vitro that was corrected by leptin supplementation 
Previous studies have reported defective phagocytic activity in obese mice (Amar, Zhou 
et al. 2007). Therefore, we assessed macrophage phagocytosis of E. chaffeensis from OB, LE 
and YO mice. Peritoneal macrophages were isolated from the three groups at day 9 after 
experimental challenge. “Obese” macrophages had a significantly lower percentage 
phagocytosed FITC labeled E. chaffeensis bacteria compared to YO mice p<0.05 (Figure 4.2). 
However, no difference was detected between the LE mice and the other two groups.  
                          
Figure 4.2 OB macrophages exhibit a low phagocytic index compared to YO and LE macrophages.  
Percent phagocytosis of FITC-labeled E. chaffeensis from E. chaffeensis infected obese (OB), age-matched lean 
(LE) and young (YO) mice at day 9 post-infection (n=6-9 per group). * p<0.05. 
 
To determine if leptin affected phagocytosis, we repeated our phagocytosis assays with 
exogenous leptin. “Obese” macrophages had a significant increase in the percentage 
phagocytosis when supplemented with 500 ng/ml rm-Leptin (p<0.05). This restored 
phagocytosis to the phagocytic levels of the YO mice. Higher concentration of leptin 
(5000ng/ml) had no added effect (Figure 4.3). YO macrophages did not respond to leptin 
supplementation and had the same phagocytic efficiency with or without leptin (p>0.05, Figure 




Figure 4.3 Leptin supplementation restored the phagocytic index of OB macrophages to that of the YO. 
Percentage phagocytosis of FITC-labeled E, chaffeensis in peritoneal macrophages isolated from E. chaffeensis 
infected obese (OB) and young (YO) mice at day 9 post-infection supplemented in vitro with 0, 500ng/ml or 
5000ng/ml rm-leptin (n=3 per supplementation group). * p<0.05. 
 
When we assayed phagocytosis of macrophages from normal mice, no differences were 
detected in phagocytic activity in macrophages coming from any group (Figure 4.4) and leptin 
supplementation had no effect on any macrophage group; not even those from OB mice (data not 
shown).  
 
               
Figure 4.4 Naïve OB, LE and YO macrophages exhibit the same phagocytic index. 
Percentage phagocytosis of FITC-labeled E, chaffeensis in peritoneal macrophages isolated from non-infected obese 





                Obesity is associated with an increased risk of infection, impaired pathogen clearance 
and a higher sepsis-related mortality and morbidity (Falagas and Kompoti 2006; Desruisseaux, 
Nagajyothi et al. 2007). The mechanisms for these compromised immune responses is not well 
understood, but leptin may play a role in this process (Mancuso, Gottschalk et al. 2002; Shapiro, 
Khankin et al. 2010). We hypothesized that upon infection, leptin levels fail to increase in 
obesity, hence negatively affecting macrophage response to bacterial pathogen and delaying 
bacterial clearance. We used a model of DIO mice followed by an i.p. injection with a 
suspension of live E. chaffeensis bacteria and monitored their systemic leptin and cytokine levels 
and bacterial clearance for nine days. 
We assessed the ability of obese mice to clear an experimental challenge of E. 
chaffeensis. We measured no differences between obese and age-matched lean mice in bacterial 
loads in mice at 6 or 9 days after challenge. This contrasts studies that showed that DIO mice 
were less capable of clearing bacterial infections compared to lean controls (Amar, Zhou et al. 
2007; Zhou, Leeman et al. 2009).  It is possible that the differences are due to the types of 
bacteria used for the challenge. E. chaffeensis is an obligate intracellular bacterium whereas 
P.gingivalis is an LPS-expressing Gram-negative pyogenic bacterium. Although both bacteria 
stimulate innate resistance through toll-like receptors, E.chaffeensis requires T-cells for most 
effective clearance. P. gingivalis LPS is recognized by macrophages through Toll-Like receptor 
2 (TLR2). Activation of this receptor leads to chronic inflammatory reactions conferring host 
protection against these bacteria. In obesity, TLR2 signaling was impaired explaining the higher 
susceptibility of DIO mice to P. gingivalis infection (Zhou, Leeman et al. 2009). The receptor 
involved in E. chaffeensis recognition is yet to be identified and the exact mechanism involved in 
the clearance of this pathogen is still to be completely defined but is believed to require both 
innate and adaptive immune mechanisms (Ganta, Cheng et al. 2007).  
We detected no difference between obese and lean mice in circulating inflammatory 
cytokines. Groups had a significant increase in both serum IL6 and TNF-α throughout the study 
period. This would be consistent with their equal ability to cure infections. However, our results 
are in disagreement with those who reported DIO mice had a blunted circulating cytokine 
response following infection with P. gingivalis.  
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All mice had decreases in serum leptin levels following E. chaffeensis infection. Serum 
leptin levels have been shown to decrease (Hultgren and Tarkowski 2001), increase (Karlsson, 
Sheridan et al. 2010) or remain unchanged (Smith, Sheridan et al. 2007) depending on the 
infectious agent (Smith, Sheridan et al. 2007; Karlsson, Sheridan et al. 2010).  In the study 
looking at influenza viral infection, leptin levels were decreased 3 days after infection in DIO 
mice whereas they were maintained in the lean group. The decrease in the obese group was 
correlated with a higher infection rate (Smith, Sheridan et al. 2007). Leptin levels significantly 
increased after influenza virus infection in lean mice but this response failed to occur in obese 
mice (Karlsson, Sheridan et al. 2010). It is possible that leptin changes were due to change in 
weight (Maffei, Halaas et al. 1995). However, despite the fact that DIO mice lost significant 
weight during our study, the weight loss does not totally account for the decrease in leptin levels 
since the young group actually gained weight but also had a significant drop in leptin levels.  
Macrophages isolated from either obese humans or mice have an impaired phagocytic 
and bactericidal activity (Krishnan, Trost et al. 1982; Mancuso, Gottschalk et al. 2002). We 
showed that macrophages isolated from infected obese mice have a decreased phagocytic activity 
in vitro compared to control macrophages and that leptin supplementation was able to restore the 
phagocytic index back to normal. Leptin supplementation in macrophages isolated from starved 
mice (low leptin levels) or leptin deficient mice have been shown to increase their pahgocytic 
activity back to regular levels (Mancuso, Huffnagle et al. 2006). This can be attributed to leptin 
activation the JAK/STAT signaling pathway, leading to stimulation of phagocytosis, production 
of oxygen and nitrogen reactive species, and secretion of pro-inflammatory cytokines by 
macrophages (Shirshev and Orlova 2005). Leptin supplementation had no effect on lean 
macrophages probably because these macrophages exhibited optimal level of phagocytosis at 
baseline.  
In conclusion, our in vivo data showed no difference in serum leptin and circulating 
cytokines or in bacterial clearance was detected in our study between DIO and age-matched lean 
mice; we believe that the use of a longer experimental period along with more traditional gram 
negative bacteria would have yielded different results. Nevertheless, we show that infected obese 




Chapter 5 - Epilogue 
 
Obesity and metabolic disease are the epidemic diseases of this century. The implication 
of the immune system and different immune cells in the pathology of obesity has led to the 
emergence of a new area of research known as “Metaflammation” or “Immunometabolism”. 
Dissecting the different pathways and mechanisms in this elaborate metabolic-immune 
interaction is of primary importance and ongoing research is gradually unraveling this intricate 
interplay of these two component systems. Leptin is investigated as the link that might explain 
the activation of the immune system in the context of obesity. The role of leptin is investigated in 
the context of diet-induced obesity on both adipose tissue inflammation and infection 
susceptibility. An in vitro model is generated to study the leptin-obesity-immunity system 
further. 
The major project (Chapter 2) “Leptin Receptor Contributes to the Metabolic and 
Inflammatory Profile of High Fat Fed Mice” examines the role of leptin in exacerbating the 
inflammatory phenotype in obese adipose tissue. Obesity is characterized by an increased 
recruitment of pro-inflammatory macrophages to the adipose tissue contributing to systemic 
inflammation and metabolic disease.  The study hypothesis states that leptin, the hormone 
secreted by adipocytes, is a major player in the enhanced macrophage recruitment in obesity. The 
main research objective is to investigate whether the lack of leptin signaling on bone marrow 
cells prevents the recruitment of pro-inflammatory macrophages to the adipose tissue of DIO 
mice. Consequently, these mice will display an improved metabolic and inflammatory profile. 
To test this hypothesis, wild type (WT) mice were irradiated and transplanted with either leptin 
receptor deficient or WT bone marrow and were randomized to either a high fat (HFD) or normal 
fat diet (NFD) for sixteen weeks.  Weight and food intake were measured weekly. Fasting blood 
sugar, insulin, leptin, MCP-1, IL-6, and TNF-α were measured at 0, 8 and 16 weeks. Adipose 
tissue morphology was assessed and liver steatosis was determined. Adipocytes gene transcript 
levels of key metabolic and inflammatory genes were assessed and adipose tissue macrophage 
phenotype - resident versus recruited pro-inflammatory- and quantification of crown-like 
structures, a measure of adipose tissue inflammation, were assessed. Mice reconstituted with 
leptin receptor-deficient bone marrow were resistant to HFD-induced weight and fat mass gain.  
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Although adipocyte size distribution was consistent with that observed under a HFD feeding, 
adipocytes from mice reconstituted with leptin receptor-deficient bone marrow had a 50% 
reduction in the expression of inflammatory genes. Epididymal fat showed significantly fewer 
crown-like structures compared to WT-reconstituted mice and most of these macrophages 
expressed Mgl1 and were CCR2-, indicative of an anti-inflammatory phenotype. Systemically, 
TNF-α and IL-6 levels were not changed from baseline in any of the groups, but leptin-receptor 
deficient mice on HFD were more insulin sensitive compared to mice reconstituted with WT. In 
conclusion, leptin through its long receptor contributes to the recruitment of pro-inflammatory 
macrophages in the adipose tissue of obese mice and the expression of the obese phenotype. 
 
The second project (Chapter 3) is entitled “Establishment and Characterization of DB-
1: A Leptin Receptor Deficient Murine Macrophage Cell Line”. A leptin receptor-deficient 
macrophage cell line, DB-1 was immortalized and characterized to provide an in vitro tool to 
investigate the link between leptin and innate immunity. The cell line was created using bone 
marrow cells from leptin-receptor deficient (db/db) mice. Bone marrow cells were differentiated 
into macrophages by culturing them with rmM-CSF, and passaged when confluent. This 
treatment was maintained for a period of six months. The cells spontaneously immortalized at 
approximately passage 20.  Cells were cloned twice by limiting dilution cloning prior to 
characterization. The macrophage cell line is diploid and has a three-day doubling time. The cells 
are MAC-2 and F4/80 positive and have phagocytic activity similar to primary macrophages 
from WT and db/db mice. DB-1 cells respond to stimulation with IFN-γ by increasing Nos2 
transcript levels. In addition, DB-1 macrophages are responsive to neither the chemotactic 
signaling of adipocyte conditioned media nor leptin when compared to primary WT 
macrophages. As a result, DB-1 cells provide a dependable tool to study the role of leptin or the 
leptin receptor in obesity-associated inflammation and immune system dysregulation.  
 
In the third study (Chapter 4) entitled: “Role of Leptin in Obesity-Associated Infection 
Susceptibility” the major hypothesis is that leptin response to infection is impaired in obesity, 
leading to a compromised immune response and defective pathogen clearance. 
Three groups of mice were experimentally challenged with Ehrlichia chaffeensis i.p.: 1) obese 2) 
age-matched lean and 3) young lean. Serum leptin and IL-6 were measured at 0, 3, 6 & 9 days 
71 
 
post-infection.  Bacterial infection was assessed at days 6 and 9 post-infection using qRT-PCR.  
The effect of leptin supplementation on macrophage phagocytosis in “obese” and “lean” 
macrophages was assessed in vitro. Peritoneal macrophages were isolated from the three groups, 
incubated with different concentrations of leptin, challenged with FITC-labeled E. chaffeensis 
and phagocytosed bacteria were quantified by FACS.  A difference in the infection between lean 
and obese mice in vivo was not detected. This is probably related to the use of these specific 
bacteria and the short experimental period. Nevertheless, results showed that obese macrophages 
have a compromised phagocytic activity in vitro, which was normalized by leptin 
supplementation.  
 
The data from the above mentioned studies suggest that leptin contributes to the 
inflammation of obesity. They also suggest that leptin affects macrophage function in obesity in 
vitro though more studies are required to assess leptin’s contribution to infection outcomes in 
vivo. Finally, DB-1 cells provide a dependable tool to study the role of leptin in obesity-
associated inflammation and immune system dysregulation further. We believe that results from 
our experiments will have the potential of elucidating the role of leptin in precipitating the 
inflammatory state associated with obesity. Further understanding this pathway will provide 
researchers the scientific background needed to help them design targeted pharmacological and 
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